<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <title>Multiple Choice Question Preparation</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <style>
    :root {
      --bg: #f8f9fb;
      --fg: #222;
      --card: #fff;
      --accent: #007bff;
      --error: #dc3545;
      --correct: #28a745;
      --border: #e5e7eb;
      --progress: #007bff;
      --progress-bg: #e9ecef;
      --outline-correct: #28a745;
      --outline-wrong: #dc3545;
      --btn-secondary-bg: #6c757d;
      --btn-secondary-fg: #fff;
    }
    body.dark {
      --bg: #18191a;
      --fg: #e4e6eb;
      --card: #242526;
      --accent: #4f8cff;
      --border: #3a3b3c;
      --progress-bg: #3a3b3c;
      --btn-secondary-bg: #4a4a4a;
      --btn-secondary-fg: #e4e6eb;
    }
    body {
      background: var(--bg);
      color: var(--fg);
      font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
      margin: 0;
      min-height: 100vh;
    }
    .container {
      max-width: 800px;
      margin: 20px auto;
      background: var(--card);
      border-radius: 12px;
      box-shadow: 0 4px 16px rgba(0,0,0,0.08);
      padding: 24px;
    }
    h1, h2, h3 {
      margin-top: 0;
      font-weight: 700;
    }
    button, input[type="file"], select, input[type="submit"] {
      background: var(--accent);
      color: #fff;
      border: none;
      padding: 10px 18px;
      border-radius: 6px;
      font-size: 1em;
      cursor: pointer;
      margin: 6px 4px 6px 0;
      outline: none;
      transition: background 0.15s;
      font-weight: 500;
    }
    button:hover, input[type="submit"]:hover {
      opacity: 0.9;
    }
    button[disabled] {
      opacity: 0.5;
      pointer-events: none;
    }
    .btn-secondary {
      background: var(--btn-secondary-bg);
      color: var(--btn-secondary-fg);
    }
    .btn-danger {
      background: var(--error);
    }
    .global-header {
      display: flex;
      justify-content: space-between;
      align-items: center;
      margin-bottom: 24px;
      flex-wrap: wrap;
    }
    .header-icons {
      display: flex;
      align-items: center;
      gap: 8px;
    }
    .icon-btn {
      font-size: 1.5em;
      background: none;
      border: none;
      color: var(--fg);
      cursor: pointer;
      padding: 5px;
    }
    .main-menu {
      display: grid;
      grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
      gap: 16px;
      margin-top: 24px;
    }
    .menu-button {
      background: var(--bg);
      border: 1.5px solid var(--border);
      padding: 20px;
      text-align: center;
      font-size: 1.2em;
      font-weight: 600;
      border-radius: 10px;
      cursor: pointer;
      transition: transform 0.2s, box-shadow 0.2s;
    }
    .menu-button:hover {
      transform: translateY(-3px);
      box-shadow: 0 4px 12px rgba(0,0,0,0.1);
      border-color: var(--accent);
    }
    .notes-section {
      margin-top: 48px;
      padding-top: 24px;
      border-top: 1px solid var(--border);
      font-size: 0.9em;
      color: #6c757d;
    }
    body.dark .notes-section {
      color: #aaa;
    }
    .notes-section p { margin: 8px 0; }
    .question-card {
      background: var(--card);
      border: 1.5px solid var(--border);
      border-radius: 10px;
      padding: 20px;
      margin-bottom: 16px;
    }
    .question-img {
      max-width: 100%;
      max-height: 250px;
      display: block;
      margin: 10px 0;
      border-radius: 8px;
    }
    .responses {
      display: flex;
      flex-direction: column;
      gap: 10px;
      margin-top: 15px;
    }
    .response-box {
      border: 1.5px solid var(--border);
      border-radius: 8px;
      padding: 12px 16px;
      font-size: 1.05em;
      cursor: pointer;
      user-select: none;
      transition: border 0.2s, background 0.2s;
      display: flex;
      align-items: center;
      gap: 12px;
    }
    .response-prefix {
      font-weight: bold;
      color: var(--accent);
    }
    .response-box.correct {
      border: 2px solid var(--outline-correct);
      background: rgba(40, 167, 69, 0.1);
    }
    .response-box.correct .response-prefix {
      color: var(--outline-correct);
    }
    .response-box.wrong {
      border: 2px solid var(--outline-wrong);
      background: rgba(220, 53, 69, 0.1);
    }
    .response-box.wrong .response-prefix {
      color: var(--outline-wrong);
    }
    .progress-bar-wrap {
      height: 16px;
      background: var(--progress-bg);
      border-radius: 8px;
      overflow: hidden;
      margin-bottom: 12px;
      margin-top: 6px;
    }
    .progress-bar {
      background: var(--progress);
      height: 100%;
      width: 0;
      transition: width 0.3s;
    }
    .score-bar {
      margin-top: 18px;
      font-size: 1.5em;
      font-weight: bold;
      text-align: center;
    }
    .score-remark {
      text-align: center;
      margin-top: 10px;
      font-style: italic;
      font-size: 1.2em;
      padding: 10px;
      border-radius: 6px;
      background: var(--bg);
    }
    .setup-form {
        border: 1.5px solid var(--border);
        padding: 20px;
        border-radius: 10px;
        margin-top: 20px;
    }
    .form-group {
        margin-bottom: 15px;
    }
    .form-group label {
        display: block;
        margin-bottom: 5px;
        font-weight: 500;
    }
    input[type="text"], input[type="number"], textarea {
      width: 100%;
      padding: 9px;
      margin: 4px 0 10px 0;
      border: 1.5px solid var(--border);
      border-radius: 6px;
      font-size: 1em;
      background: var(--bg);
      color: var(--fg);
      outline: none;
      box-sizing: border-box;
    }
    .range-input {
        display: flex;
        gap: 10px;
        align-items: center;
    }
    .range-input input {
        width: 100px;
    }
    .instruction-page p {
      line-height: 1.6;
      margin-bottom: 1em;
    }
    .instruction-page h3 {
      margin-top: 1.5em;
    }
    @media(max-width: 700px) {
      .container { padding: 18px 4vw; }
      .main-menu { grid-template-columns: 1fr; }
    }
  </style>
</head>
<body>

<audio id="bg-music" loop></audio>
<div class="container" id="app"></div>

<script>
// --- Data structure, Keys, and Constants ---
const MAIN_BANK_KEY = "mcq_main_bank_v4";
const MEMORY_LIST_KEY = "mcq_memory_list_v4";
const SETTINGS_KEY = "mcq_settings_v4";

// IMPORTANT: Replace this placeholder with your own Base64 music string
const musicBase64 = "data:audio/mpeg;base64,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";

// --- State Management ---
function getDefaultState() {
  return {
    view: "menu",
    mainQuestionBank: [
       {
    question: "Les Anti-Herptique: cocher une rponse fausse",
    img: "",
    responses: [
      "Aciclovir",
      "Valaciclovir",
      "Famciclovir",
      "ZOVIRAX",
      "Tnofovir"
    ],
    correct: 4
  },
  {
    question: "Les anti-CMV: cocher une rponse fausse",
    img: "",
    responses: [
      "Ganciclovir",
      "Valganciclovir",
      "Cidofovir",
      "CYMEVAN",
      "Entcavir"
    ],
    correct: 4
  },
  {
    question: "Les anti-grippaux: cocher une rponse vraie",
    img: "",
    responses: [
      "ZOVIRAX",
      "ZELITREX",
      "ORAVIR",
      "Valaciclovir",
      "TAMINFLU"
    ],
    correct: 4
  },
  {
    question: "Les mdicaments anti-Hpatite B: cocher une rponse fausse",
    img: "",
    responses: [
      "Lamivudine",
      "Adfovir",
      "Tnofovir",
      "3TC",
      "Abacavir"
    ],
    correct: 4
  },
  {
    question: "Les mdicaments anti-Hpatite B (mdicament injectable): cocher une rponse vraie",
    img: "",
    responses: [
      "Lamivudine",
      "Adfovir",
      "Tnofovir",
      "3TC",
      "Interfron"
    ],
    correct: 4
  },
  {
    question: "Les mdicaments anti-Hpatite B (mdicament premier choix): cocher une rponse vraie",
    img: "",
    responses: [
      "Lamivudine",
      "Adfovir",
      "Tnofovir",
      "3TC",
      "Telbivudine"
    ],
    correct: 2
  },
  {
    question: "Les mdicaments anti-Hpatite B: cocher une rponse fausse",
    img: "",
    responses: [
      "ZEFFIX",
      "3TC",
      "D4T",
      "EPIVIR",
      "Lamivudine"
    ],
    correct: 2
  },
  {
    question: "Les mdicaments anti-Hpatite C: cocher une rponse fausse",
    img: "",
    responses: [
      "Copegus",
      "Ribavirine",
      "Entecavir",
      "Vilona",
      "Rebetol"
    ],
    correct: 2
  },
  {
    question: "Les mdicaments pur traiter l'hpatite C: cocher une rponse fausse",
    img: "",
    responses: [
      "Copegus + Entcavir",
      "Ribavirine + IFN",
      "Daclastasvir + Sofosbuvir",
      "Vilona + Peg IFN",
      "Rebetol + Sofosbuvir"
    ],
    correct: 0
  },
  {
    question: "Les mdicaments anti-Hpatite C (DAA): cocher une rponse fausse",
    img: "",
    responses: [
      "Sofosbuvir",
      "Ladipasvir",
      "PEG IFN Alpha",
      "Daclastavir",
      "HARVONI"
    ],
    correct: 2
  },
  {
    question: "Les anti-parasitaires: cocher une rponse fausse",
    img: "",
    responses: [
      "Anti paluden",
      "Anti amibienne",
      "Antihelminthique",
      "Antiprotozoaire",
      "Anti mycosique"
    ],
    correct: 4
  },
  {
    question: "Les anti-paludens: cocher une rponse fausse",
    img: "",
    responses: [
      "Chloroquine",
      "Mfloquine",
      "Artsunate",
      "Artmther",
      "Quinolone"
    ],
    correct: 4
  },
  {
    question: "Les anti-amibienne: cocher une rponse vraie",
    img: "",
    responses: [
      "Mtronidazole",
      "Quinine",
      "Quinidine",
      "Doxycycline",
      "Chloroquine"
    ],
    correct: 0
  },
  {
    question: "Mtronidazole pour traiter cocher une rponse fausse",
    img: "",
    responses: [
      "Abcs hpatique",
      "Sd dysentrie",
      "Amoebome",
      "Trichomonas",
      "Traitement HBV"
    ],
    correct: 4
  },
  {
    question: "Les anti helminthiques: cocher une rponse fausse",
    img: "",
    responses: [
      "Albendazole",
      "Mbendazole",
      "Ivermectine",
      "Stromectol",
      "Tinidazole"
    ],
    correct: 4
  },
  {
    question: "What is the recommended standard treatment duration for leprosy?",
    img: "",
    responses: [
      "6 months for children and 12 months for adults",
      "1 or 2 months depending on the operational or clinical classification of the disease",
      "6 or 8 months depending on the operational or clinical classification of the disease",
      "6 or 12 months depending on the operational or clinical classification of the disease",
      "12 or 18 months depending on the operational or clinical classification of the disease"
    ],
    correct: 3
  },
  {
    question: "WHO regime for paucibacillary leprosy (PB) in adult is:",
    img: "",
    responses: [
      "50mg Dapsone daily + 450mg Rifampien monthly",
      "100mg Dapsone daily + 600mg Rifampien daily",
      "300mg Clofazimine daily + 300mg Rifampcin daily",
      "100mg Dapsone daily + 600mg Rifampicin monthly",
      "100mg Dapsone + 600mg Rifampcin + 300mg Clofazimine daily"
    ],
    correct: 3
  },
  {
    question: "Dose of Rifampicin recommended in multibacillary leprosy in adult is 600 mg",
    img: "",
    responses: [
      "Once daily",
      "Once in a week",
      "Twice weekly",
      "Once in a month",
      "Twice monthly"
    ],
    correct: 3
  },
  {
    question: "What is the Mechanism of action of Dapsone against Mycobacterium leprae?",
    img: "",
    responses: [
      "Inhibits RNA synthesis.",
      "Inhibition of dihydropteroate synthase",
      "Inhibition of neutrophil and eosinophil myeloperoxidase",
      "Inhibits mycobacterial arabinosyltransferases.",
      "Prevents bacterial protein synthesis by binding to the S12 ribosomal subunit."
    ],
    correct: 1
  },
  {
    question: "Which statement is true about pharmacokinetic of Dapsone?",
    img: "",
    responses: [
      "Half-life may be 2 months.",
      "Absorption from the gut is variable.",
      "It is slowly released from the deposits.",
      "Major portion of the drug is excreted in feces.",
      "Skin heavily infected with M leprae may contain more drug"
    ],
    correct: 4
  },
  {
    question: "Which statement is true about pharmacokinetic of Dapsone?",
    img: "",
    responses: [
      "Half-life may be 2 months.",
      "Excretion into bile and urine",
      "It is slowly released from the deposits.",
      "Major portion of the drug is excreted in feces.",
      "Cross the placenta, and is found in human breast milk"
    ],
    correct: 4
  },
  {
    question: "What is the common adverse reactions of Dapsone?",
    img: "",
    responses: [
      "Ototoxic and Nephrotoxic",
      "Methemoglobinemia",
      "Hyperuricemia may provoke acute gouty arthritis",
      "Harmless orange color to urine, sweats, tears, and contact lenses",
      "Retrobulbar neuritis, resulting in loss of visual acuity and red-green color blindness"
    ],
    correct: 1
  },
  {
    question: "What is the Mechanism of action of Rifampicin against Mycobacterium leprae?",
    img: "",
    responses: [
      "Inhibition of dihydropteroate synthase",
      "Inhibits mycobacterial arabinosyltransferases",
      "Inhibition of neutrophil and eosinophil myeloperoxidase",
      "Inhibits bacterial DNA-dependent RNA synthesis",
      "Prevents bacterial protein synthesis by binding to the S12 ribosomal subunit."
    ],
    correct: 3
  },
  {
    question: "Which statement is true about pharmacokinetic of Rifampicin?",
    img: "",
    responses: [
      "Half-life may be 2 months.",
      "Excreted in the feces, small amount in the urine",
      "It is slowly released from the deposits.",
      "Major portion of the drug is excreted in feces.",
      "Skin heavily infected with M leprae may contain more drug"
    ],
    correct: 1
  },
  {
    question: "What is the most common adverse reactions of Rifampicin?",
    img: "",
    responses: [
      "Methemoglobinemia is common",
      "Gastrointestinal intolerance occurs occasionally",
      "Loss of visual acuity and red-green color blindness",
      "Hemolysis, particularly if they have G6PD deficiency",
      "Harmless orange color to urine, sweats, tears, and contact lenses"
    ],
    correct: 4
  },
  {
    question: "What is the common adverse reactions of Rifampicin?",
    img: "",
    responses: [
      "Erythema nodosumleprosum",
      "Flu-like syndrome and thrombocytopenia",
      "Hemolysis, particularly if they have G6PD deficiency",
      "Hyperuricemia may provoke acute gouty arthritis",
      "Skin discoloration ranging from red-brown to nearly black"
    ],
    correct: 1
  },
  {
    question: "Which statement is the mechanism of actionof Clofazimine?",
    img: "",
    responses: [
      "Inhibition of RNA synthesis.",
      "Inhibition of dihydropteroate synthase",
      "Inhibition of mycobacterial arabinosyltransferases",
      "Inhibition of neutrophil and eosinophil myeloperoxidase",
      "Inhibition of mycobacterial growth and binds preferentially to mycobacterial DNA"
    ],
    correct: 4
  },
  {
    question: "Which statement is true about pharmacokinetic of Clofazimine?",
    img: "",
    responses: [
      "Excreted in urine",
      "Cross the blood-brain barrier",
      "Excreted in the feces, small amount in the urine",
      "Half-life is variable, with values as long as 70 days.",
      "Skin heavily infected with M leprae may contain more drug"
    ],
    correct: 3
  },
  {
    question: "Which statement is true about pharmacokinetic of Clofazimine?",
    img: "",
    responses: [
      "Half-life may be 2 months",
      "Metabolism: not known",
      "Cross the blood-brain barrier",
      "Cross the placenta, and is found in human breast milk",
      "Skin heavily infected with M leprae may contain several times more drug than normal skin"
    ],
    correct: 3
  },
  {
    question: "Which statement is the adverse reaction of Clofazimine?",
    img: "",
    responses: [
      "Erythema nodosumleprosum",
      "Gastrointestinal intolerance, fever, pruritus.",
      "Hemolysis, particularly if they have G6PD deficiency",
      "Skin discoloration ranging from pink to brownish-black",
      "Methemoglobinemia is common, but usually is not a problem clinically"
    ],
    correct: 3
  },
  {
    question: "Which statement is the adverse reaction of Clofazimine?",
    img: "",
    responses: [
      "Ichthyosis and dryness",
      "Erythema nodosumleprosum",
      "Gastrointestinal intolerance, fever, pruritus.",
      "Hemolysis, particularly if they have G6PD deficiency",
      "Methemoglobinemia is common, but usually is not a problem clinically"
    ],
    correct: 0
  },
  {
    question: "A young female patient using an oral contraceptive is to be treated for leprosy. She is advised to use an additional method of contraception since the efficacy of the oral agents is commonly decreased if her drug regimen includes:",
    img: "",
    responses: [
      "Dapsone",
      "Rifampicin",
      "Clofazimine",
      "Minocycline",
      "Ofloxacin"
    ],
    correct: 1
  },
  {
    question: "A patient taking Anti-leprosy treatment, then he has symptoms as \"orange colors to urine, sweat, tears, and contact lenses\". Which one of the following medicine can cause this adverse reaction?",
    img: "",
    responses: [
      "Dapsone",
      "Rifampicin",
      "Clofazimine",
      "Minocycline",
      "Ofloxacin"
    ],
    correct: 1
  },
  {
    question: "A patient taking Anti-leprosy treatment, then he has \"Erythema nodosum leprosum\". Which one of the following medicine can cause this adverse reaction?",
    img: "",
    responses: [
      "Dapsone",
      "Rifampicin",
      "Clofazimine",
      "Minocycline",
      "Clarithromycin"
    ],
    correct: 0
  },
  {
    question: "A patient taking Anti-leprosy treatment, then he has symptoms as \"Flu-like syndrome and thrombocytopenia\". Which one of the following medicine can cause this adverse reaction?",
    img: "",
    responses: [
      "Dapsone",
      "Rifampicin",
      "Clofazimine",
      "Minocycline",
      "Clarithromycin"
    ],
    correct: 1
  },
  {
    question: "A patient taking Anti-leprosy treatment, then he has symptoms as \"Ichthyosis and dryness\". Which one of the following medicine can cause this adverse reaction?",
    img: "",
    responses: [
      "Dapsone",
      "Rifampicin",
      "Clofazimine",
      "Minocycline",
      "Clarithromycin"
    ],
    correct: 2
  },
  {
    question: "A patient taking Anti-leprosy treatment, then he has \"hemolytic anemia\". Which one of the following medicine can cause this adverse reaction?",
    img: "",
    responses: [
      "Dapsone",
      "Rifampicin",
      "Clofazimine",
      "Minocycline",
      "Clarithromycin"
    ],
    correct: 0
  },
  {
    question: "A patient taking Anti-leprosy treatment, then he has symptoms as \"Blurred vision, paraesthesia\". Which one of the following medicine can cause this adverse reaction?",
    img: "",
    responses: [
      "Dapsone",
      "Rifampicin",
      "Clofazimine",
      "Minocycline",
      "Clarithromycin"
    ],
    correct: 0
  },
  {
    question: "Which of the following drugs may cause \"risk of postnatal haemorrhage\"?",
    img: "",
    responses: [
      "Dapsone",
      "Rifampicin",
      "Clofazimine",
      "Minocycline",
      "Clarithromycin"
    ],
    correct: 1
  },
  {
    question: "Skin pigmentation and icthyosis like side effects are seen in patient who received:",
    img: "",
    responses: [
      "Rifampcin",
      "Clofazimine",
      "Dapsone",
      "Steroid",
      "Thalidomide"
    ],
    correct: 1
  },
  {
    question: "A patient taking Anti-leprosy treatment, then he come back because his skin is dusty, his tongue and lips are blue. He has headache and also tired because of you. His SaO2 is low. Which is the following drugs my cause this side effects?",
    img: "",
    responses: [
      "Dapsone",
      "Rifampicin",
      "Clofazimine",
      "Minocycline",
      "Clarithromycin"
    ],
    correct: 0
  },
  {
    question: "What is the Mechanism of Action of INH against M tuberculosis?",
    img: "",
    responses: [
      "Inhibits RNA synthesis.",
      "Inhibits synthesis of mycolic acids.",
      "Inhibits mycobacterial arabinosyltransferases.",
      "Converted to the active pyrazinoic acid under acidic conditions of macrophage lysosomes.",
      "Prevents bacterial protein synthesis by binding to the S12 ribosomal subunit."
    ],
    correct: 1
  },
  {
    question: "What is the most common adverse reactions of INH?",
    img: "",
    responses: [
      "Ototoxic and Nephrotoxic.",
      "The risk of peripheral neuropathy",
      "Flu-like syndrome and thrombocytopenia",
      "Harmless orange color to urine, sweats, tears, and contact lenses.",
      "Retrobulbar neuritis, resulting in loss of visual acuity and red-green color blindness."
    ],
    correct: 1
  },
  {
    question: "Isoniazid may cause peripheral neuropathy and anaemia as its side effects because",
    img: "",
    responses: [
      "It is toxic to nerves and to red blood cells.",
      "It is a type of hypersensitivity reaction.",
      "It prevents absorption of iron and ascorbic acid.",
      "It interferes with pyridoxine metabolism and induces its deficiency."
    ],
    correct: 3
  },
  {
    question: "What is the Mechanism of action Rifampicin against TB?",
    img: "",
    responses: [
      "Inhibits RNA synthesis.",
      "Inhibits synthesis of mycolic acids.",
      "Inhibits mycobacterial arabinosyltransferases.",
      "Converted to the active pyrazinoic acid under acidic conditions of macrophage lysosomes.",
      "Prevents bacterial protein synthesis by binding to the S12 ribosomal subunit."
    ],
    correct: 0
  },
  {
    question: "What is the Mechanism of action EMB against TB?",
    img: "",
    responses: [
      "Inhibits RNA synthesis.",
      "Inhibits synthesis of mycolic acids.",
      "Inhibits mycobacterial arabinosyltransferases.",
      "Converted to the active pyrazinoic acid under acidic conditions of macrophage lysosomes.",
      "Prevents bacterial protein synthesis by binding to the $12 ribosomal subunit."
    ],
    correct: 2
  },
  {
    question: "What is the most common adverse reactions of EMB?",
    img: "",
    responses: [
      "Acute gouty arthritis.",
      "Ototoxic and Nephrotoxic.",
      "Harmless orange color to urine, sweats, tears, and contact lenses.",
      "Retrobulbar neuritis, resulting in loss of visual acuity and red-green color blindness.",
      "Peripheral neuropathy and CNS toxicity: memory loss, psychosis, and seizures."
    ],
    correct: 3
  },
  {
    question: "What is the most common adverse reactions of PZA?",
    img: "",
    responses: [
      "Ototoxic and Nephrotoxic.",
      "Hyperuricemia may provoke acute gouty arthritis.",
      "Harmless orange color to urine, sweats, tears, and contact lenses.",
      "Retrobulbar neuritis, resulting in loss of visual acuity and red-green color blindness.",
      "Peripheral neuropathy and CNS toxicity: memory loss, psychosis, and seizures."
    ],
    correct: 1
  },
  {
    question: "A young female patient using an oral contraceptive is to be treated for pulmonary tuberculosis. She is advised to use an additional method of contraception since the efficacy of the oral agents is commonly decreased if her drug regimen includes:",
    img: "",
    responses: [
      "Streptomycin",
      "Ethambutol",
      "Isoniazid",
      "Pyrazinamide",
      "Rifampicin"
    ],
    correct: 4
  },
  {
    question: "What is the most common toxicity of streptomycin?",
    img: "",
    responses: [
      "Ototoxic and Nephrotoxic.",
      "Rashes, thrombocytopenia, and nephritis.",
      "Hyperuricemia may provoke acute gouty arthritis.",
      "Retrobulbar neuritis, resulting in loss of visual acuity and red-green color blindness.",
      "Immunologic Reactions, Hepatitis and Peripheral neuropathy."
    ],
    correct: 0
  },
  {
    question: "Which of the following drugs, inhibits mycobacterial arabinosyl transferases?",
    img: "",
    responses: [
      "Isoniazid",
      "Rifampin",
      "Ethambutol",
      "Pyrizinamide",
      "Streptomycin"
    ],
    correct: 2
  },
  {
    question: "A patient taking Anti-tuberculosis treatment, then he has an symptoms as \"peripheral neuropathy. Which one of the following medicines can cause this adverse reaction?",
    img: "",
    responses: [
      "Isoniazid",
      "Rifampicin",
      "Ethambutol",
      "Pyrizinamide",
      "Streptomycin"
    ],
    correct: 0
  },
  {
    question: "A patient taking Anti-tuberculosis treatment, then he has symptoms as \"orange colors to urine, sweat, tears, and contact lenses\". Which one of the following medicine can cause this adverse reaction?",
    img: "",
    responses: [
      "Isoniazid",
      "Rifampicin",
      "Ethambutol",
      "Pyrizinamide",
      "Streptomycin"
    ],
    correct: 1
  },
  {
    question: "A patient taking Anti-tuberculosis treatment, then he has symptoms as \"arthralgia with biological sign of Hyperuricemia\". Which one of the following medicine can cause this adverse reaction?",
    img: "",
    responses: [
      "Isoniazid",
      "Rifampicin",
      "Ethambutol",
      "Pyrizinamide",
      "Streptomycin"
    ],
    correct: 3
  },
  {
    question: "The primary reason for the use of drug combinations in the treatment of tuberculosis is to:",
    img: "",
    responses: [
      "Reduce the incidence of adverse effects.",
      "Delay or prevent the emergence of resistance.",
      "Ensure patient compliance with the drug regimen.",
      "Provide prophylaxis against other bacterial infections.",
      "Enhance activity against metabolically inactive mycobacteria."
    ],
    correct: 1
  },
  {
    question: "Pyridoxine is given to a patient of tuberculosis prevents",
    img: "",
    responses: [
      "INH induced peripheral neuritis",
      "Rifampicin induced hepatotoxicity",
      "Ethambutol induced visual defects",
      "Pyrazinamide induced neurotoxicity",
      "Streptomycin induced nephrotoxicity"
    ],
    correct: 0
  },
  {
    question: "What is the Mechanism of Action of Isoniazid against M tuberculosis? Choose one best answer.",
    img: "",
    responses: [
      "Inhibits RNA synthesis.",
      "Inhibits synthesis of mycolic acids.",
      "Inhibits mycobacterial arabinosyltransferases.",
      "Converted to the active pyrazinoic acid under acidic conditions of macrophage lysosomes.",
      "Prevents bacterial protein synthesis by binding to the S12 ribosomal subunit."
    ],
    correct: 1
  },
  {
    question: "What is the most common adverse reactions of Isoniazid? Choose one best answer.",
    img: "",
    responses: [
      "Ototoxic and Nephrotoxic.",
      "The risk of peripheral neuropathy",
      "Flu-like syndrome and thrombocytopenia",
      "Harmless orange color to urine, sweats, tears, and contact lenses.",
      "Retrobulbar neuritis, resulting in loss of visual acuity and red-green color blindness."
    ],
    correct: 1
  },
  {
    question: "Isoniazid may cause peripheral neuropathy and anaemia as its side effects because",
    img: "",
    responses: [
      "It is toxic to nerves and to red blood cells.",
      "It is a type of hypersensitivity reaction.",
      "It prevents absorption of iron and ascorbic acid.",
      "It interferes with pyridoxine metabolism and induces its deficiency."
    ],
    correct: 3
  },
  {
    question: "What is the Mechanism of action Rifampicin against TB? Choose one best answer.",
    img: "",
    responses: [
      "Inhibits RNA synthesis.",
      "Inhibits synthesis of mycolic acids.",
      "Inhibits mycobacterial arabinosyltransferases.",
      "Converted to the active pyrazinoic acid under acidic conditions of macrophage lysosomes.",
      "Prevents bacterial protein synthesis by binding to the S12 ribosomal subunit."
    ],
    correct: 0
  },
  {
    question: "What is the most common adverse reactions of Rifampicin? Choose one best answer.",
    img: "",
    responses: [
      "Ototoxic and Nephrotoxic.",
      "Lupus-like syndrome, pellagra, arthralgia",
      "Harmless orange color to urine, sweats, tears, and contact lenses.",
      "Retrobulbar neuritis, resulting in loss of visual acuity and red-green color blindness.",
      "Peripheral neuropathy and CNS toxicity: memory loss, psychosis, and seizures."
    ],
    correct: 2
  },
  {
    question: "What is the Mechanism of action Ethambutol against TB? Choose one best answer.",
    img: "",
    responses: [
      "Inhibits RNA synthesis.",
      "Inhibits synthesis of mycolic acids.",
      "Inhibits mycobacterial arabinosyltransferases.",
      "Converted to the active pyrazinoic acid under acidic conditions of macrophage lysosomes.",
      "Prevents bacterial protein synthesis by binding to the S12 ribosomal subunit."
    ],
    correct: 2
  },
  {
    question: "What is the most common adverse reactions of Ethambutol? Choose one best answer.",
    img: "",
    responses: [
      "Acute gouty arthritis.",
      "Ototoxic and Nephrotoxic.",
      "Harmless orange color to urine, sweats, tears, and contact lenses.",
      "Retrobulbar neuritis, resulting in loss of visual acuity and red-green color blindness.",
      "Peripheral neuropathy and CNS toxicity: memory loss, psychosis, and seizures."
    ],
    correct: 3
  },
  {
    question: "Which statement is true about Pharmacokinetics of Pyrazinamide? Choose one best answer.",
    img: "",
    responses: [
      "Half-life: 3-4 h, metabolized by the liver, about 20% is excreted unchanged in the feces.",
      "Half-life: 3-5 h, metabolized by the liver, about 20% is excreted unchanged in the feces.",
      "Half-life: 8-11h, metabolized by the liver, excreted in the urine.",
      "Half-life: 8-11h, not metabolized in the body and eliminate with active form."
    ],
    correct: 2
  },
  {
    question: "What is the most common adverse reactions of Pyrazinamide? Choose one best answer.",
    img: "",
    responses: [
      "Ototoxic and Nephrotoxic.",
      "Hyperuricemia may provoke acute gouty arthritis.",
      "Harmless orange color to urine, sweats, tears, and contact lenses.",
      "Retrobulbar neuritis, resulting in loss of visual acuity and red-green color blindness.",
      "Peripheral neuropathy and CNS toxicity: memory loss, psychosis, and seizures."
    ],
    correct: 1
  },
  {
    question: "A young female patient using an oral contraceptive is to be treated for pulmonary tuberculosis. She is advised to use an additional method of contraception since the efficacy of the oral agents is commonly decreased if her drug regimen includes",
    img: "",
    responses: [
      "Streptomycin",
      "Ethambutol",
      "Isoniazid",
      "Pyrazinamide",
      "Rifampicin"
    ],
    correct: 4
  },
  {
    question: "What is the most common toxicity of Streptomycin? Choose one best answer.",
    img: "",
    responses: [
      "Ototoxic and Nephrotoxic.",
      "Rashes, thrombocytopenia, and nephritis.",
      "Hyperuricemia may provoke acute gouty arthritis.",
      "Retrobulbar neuritis, resulting in loss of visual acuity and red-green color blindness.",
      "Immunologic Reactions, Hepatitis and Peripheral neuropathy."
    ],
    correct: 0
  },
  {
    question: "Which of the following drugs, inhibits mycobacterial arabinosyl transferases? Choose one best answer.",
    img: "",
    responses: [
      "Isoniazid",
      "Rifampin",
      "Ethambutol",
      "Pyrizinamide",
      "Streptomycin"
    ],
    correct: 2
  },
  {
    question: "A patient taking Anti-tuberculosis treatment, then he has a symptom as peripheral neuropathy. Which one of the following medicines can cause this adverse reaction? Choose one best answer.",
    img: "",
    responses: [
      "Isoniazid",
      "Rifampicin",
      "Ethambutol",
      "Pyrizinamide",
      "Streptomycin"
    ],
    correct: 0
  },
  {
    question: "A patient taking Anti-tuberculosis treatment, then he has symptoms as orange colors to urine, sweat, tears, and contact lenses. Which one of the following medicine can cause this adverse reaction? Choose one best answer.",
    img: "",
    responses: [
      "Isoniazid",
      "Rifampicin",
      "Ethambutol",
      "Pyrizinamide",
      "Streptomycin"
    ],
    correct: 1
  },
  {
    question: "A patient taking Anti-tuberculosis treatment, then he has symptoms as arthralgia with biological sign of Hyperuricemia. Which one of the following medicine can cause this adverse reaction? Choose one best answer.",
    img: "",
    responses: [
      "Isoniazid",
      "Rifampicin",
      "Ethambutol",
      "Pyrizinamide",
      "Streptomycin"
    ],
    correct: 3
  },
  {
    question: "The primary reason for the use of drug combinations in the treatment of tuberculosis is to",
    img: "",
    responses: [
      "Reduce the incidence of adverse effects.",
      "Delay or prevent the emergence of resistance.",
      "Ensure patient compliance with the drug regimen.",
      "Provide prophylaxis against other bacterial infections.",
      "Enhance activity against metabolically inactive mycobacteria."
    ],
    correct: 1
  },
  {
    question: "Pyridoxine is given to a patient of tuberculosis prevents",
    img: "",
    responses: [
      "INH induced peripheral neuritis",
      "Rifampicin induced hepatotoxicity",
      "Ethambutol induced visual defects",
      "Pyrazinamide induced neurotoxicity",
      "Streptomycin induced nephrotoxicity"
    ],
    correct: 0
  },
  {
    question: "What is the recommended standard treatment duration for leprosy?",
    img: "",
    responses: [
      "6 months for children and 12 months for adults",
      "1 or 2 months depending on the operational or clinical classification of the disease",
      "6 or 8 months depending on the operational or clinical classification of the disease",
      "6 or 12 months depending on the operational or clinical classification of the disease",
      "12 or 18 months depending on the operational or clinical classification of the disease"
    ],
    correct: 3
  },
  {
    question: "WHO regime for paucibacillary leprosy (PB) in adult is:",
    img: "",
    responses: [
      "50mg Dapsone daily + 450mg Rifampicn monthly",
      "100mg Dapsone daily + 600mg Rifampicn daily",
      "300mg Clofazimine daily + 300mg Rifampcin daily",
      "100mg Dapsone daily + 600mg Rifampicin monthly",
      "100mg Dapsone + 600mg Rifampcin + 300mg Clofazimine daily"
    ],
    correct: 3
  },
  {
    question: "Which statement is true about pharmacokinetic of Dapsone? Choose one best answer.",
    img: "",
    responses: [
      "Half-life may be 2 months.",
      "Absorption from the gut is variable.",
      "It is slowly released from the deposits.",
      "Major portion of the drug is excreted in feces.",
      "Skin heavily infected with M leprae may contain more drug"
    ],
    correct: 4
  },
  {
    question: "Which statement is correct about adverse reactions of Dapsone? Choose one best answer.",
    img: "",
    responses: [
      "Methemoglobinemia is common.",
      "Gastrointestinal intolerance occurs occasionally.",
      "Loss of visual acuity and red-green color blindness.",
      "Skin discoloration ranging from red-brown to nearly black.",
      "It may cause cholestatic jaundiceand occasionally hepatitis"
    ],
    correct: 0
  },
  {
    question: "Dose of rifampicin recommended in multibacillary leprosy in adult is 600 mg",
    img: "",
    responses: [
      "Once daily",
      "Once in a week",
      "Twice weekly",
      "Once in a month",
      "Twice monthly"
    ],
    correct: 3
  },
  {
    question: "Which statement is the adverse reaction of Clofazimine? Choose one best answer.",
    img: "",
    responses: [
      "Gastrointestinal intolerance, fever, pruritus.",
      "Erythema nodosumleprosum often develops.",
      "Skin discoloration ranging from pink to brownish-black.",
      "Hemolysis, particularly if they have G6PD deficiency.",
      "Methemoglobinemia is common, but usually is not a problem clinically."
    ],
    correct: 2
  },
  {
    question: "A patient taking Anti-leprosy treatment, then he come back with his lawyer because his skin is dusty, his tongue and lips are blue...and he threatens to sue....He has headache and also tired because of you. His SaO2 is low. Which one of the following drugs can cause this adverse reaction?",
    img: "",
    responses: [
      "Rifampcin",
      "Clofazimine",
      "Dapsone",
      "Steroid",
      "Thalidomide"
    ],
    correct: 2
  },
  {
    question: "Definition de la pharmacodpendance ? (cocher sur 1 rponse juste)",
    img: "",
    responses: [
      "Ltude des effets des mdicaments",
      "Ltude des effets indsirables des mdicaments",
      "La rptition de lutilisation des Canabis",
      "Limpossibilit pour un organisme de fonctionner correctement sans le mdicament auquel il sest accoutum",
      "Ltude de passage de mdicament dans lorganisme"
    ],
    correct: 3
  },
  {
    question: "Les substances qui provoquent la toxicomanie sont class en (cocher sur 1 rponse juste)",
    img: "",
    responses: [
      "2 groupes",
      "3 groupes",
      "4 groupes",
      "5 groupes",
      "6 groupes"
    ],
    correct: 3
  },
  {
    question: "Lalcool thylique est class dans le groupe ( cocher sur 1 rponse juste)",
    img: "",
    responses: [
      "Hallucinogne",
      "Enivrants",
      "Excitants",
      "Tranquilisant",
      "Opiacs"
    ],
    correct: 1
  },
  {
    question: "Lther est ( cocher sur 1 rponse fausse)",
    img: "",
    responses: [
      "Class dans le groupe des nivrants",
      "Pyschostimulant",
      "Produit dopant",
      "Provoque le dcharge des catcholamines endogne",
      "est un produit anesthsique"
    ],
    correct: 3
  },
  {
    question: "Pharmacodynamique ? (cocher sur 1 rponse juste)",
    img: "",
    responses: [
      "tude des effets secondaires des mdicaments",
      "tude du actions de mdicament dans lorganisme",
      "tude de mtabolisme des mdicaments",
      "tude des liminations des mdicaments",
      "tude des fabrication des mdicaments"
    ],
    correct: 1
  },
  {
    question: "Les rgles de base de la pharmacologie ? (cocher sur 1 rponse fausse)",
    img: "",
    responses: [
      "Posologie",
      "Mode dadministration",
      "Indications clinique",
      "Contre-indication",
      "Etude le prix des mdicaments"
    ],
    correct: 4
  },
  {
    question: "Pharmacologie fondamentale ? (cocher sur 1 rponse fausse)",
    img: "",
    responses: [
      "Mthode de biologie molculaire",
      "Mthode dexpertise toxicologie",
      "Mthode de la physiolic exprimentale",
      "Mthode de la Criblage",
      "Ltude des effets des mdicaments chez lhomme"
    ],
    correct: 4
  },
  {
    question: "Fonctions du mdicament, (cocher sur 1 rponse fausse)",
    img: "",
    responses: [
      "Prventive individuelle",
      "Prventive collective",
      "Traitement substitutive",
      "Traitement curative",
      "Toxique"
    ],
    correct: 4
  },
  {
    question: "Origine des mdicaments (cocher sur 1 rponse fausse)",
    img: "",
    responses: [
      "Origine vgtale",
      "Origine animale",
      "Origine synthtique",
      "Origine biogntique",
      "Origine biologique"
    ],
    correct: 3
  },
  {
    question: "Dnomination des mdicaments (cocher sur 1 rponse fausse)",
    img: "",
    responses: [
      "Nom chimique",
      "DCI",
      "Nom de marque",
      "Dnominations Communes Internationales",
      "Nom de mdicaments du prix lev"
    ],
    correct: 4
  },
  {
    question: "Pharmacocintique de lthanol (cocher sur 1 rponse fausse)",
    img: "",
    responses: [
      " jeun le pic de concentration atteint en 30mn",
      "Lestomac plein augmente labsorption",
      "90% oxyd dans le foie, le reste est excrt par le rein et le poumon",
      "Ladulte peur mtaboliser 7  10g dalcool par heure",
      "La barrire hmato-encphalique est trs permable  lthanol"
    ],
    correct: 1
  },
  {
    question: "Action sur le systme nerveux central suivant, Le taux alcoolmie (g /l) (cocher sur 1 rponse fausse)",
    img: "",
    responses: [
      "0.5-1 sdation, euphorie",
      "1-2 altration de la motricit",
      "2-3 vomissement, somnolence",
      "5 coma",
      "> 5 dpression respiratioire"
    ],
    correct: 3
  },
  {
    question: "Consquence dune consommation chronique de lalcool sur le foie et tube digestif (cocher 1 rponse fausse)",
    img: "",
    responses: [
      "Statose hpatique",
      "Cirrhose du foie",
      "Pancratite",
      "Oesophagite",
      "Gastrite"
    ],
    correct: 3
  },
  {
    question: "Consquence dune consommation chronique de lalcool sur le systme endocrine (cocher 1 rponse fausse)",
    img: "",
    responses: [
      "Gyncomastie",
      "Hyperglycmie",
      "Atrophie musculaire",
      "Hyperaldostronisme secondaire grave",
      "Trouble de lquilibre hydro-letrolytique"
    ],
    correct: 1
  },
  {
    question: "Le mdicament qui donne effet (Autabuse) (cocher sur 1 rponse juste)",
    img: "",
    responses: [
      "Aspirine",
      "Ampicilline",
      "Mtronidazole",
      "Laroscorbine",
      "Gentamycine"
    ],
    correct: 2
  },
  {
    question: "Au cours de la grossesse labus chronique de lalcool provoque (cocher sur 1 rponse fausse)",
    img: "",
    responses: [
      "Retard de croissance intra-utrin",
      "Une microcphalie",
      "Mauvaise coordination motrice",
      "Des anomalies articulaire mineurs",
      "Paralysie des membres"
    ],
    correct: 4
  },
  {
    question: "Abbviation dun mdicament antirtrovirale de Inhibiteur nucloside de transcriptase inverse, autrefois utilis comme antivirus de lhpatite .B (cocher sur 1 rponse fausse)",
    img: "",
    responses: [
      "D4T",
      "3TC",
      "AZT",
      "DDI",
      "ABC"
    ],
    correct: 0
  },
  {
    question: "Un antirtroviral trs utiliser dans le derneir trimeste de grossesse pour viter la contamination de la mre au nouveau-n (cocher sur 1 rponse juste)",
    img: "",
    responses: [
      "Lamivudine",
      "Nvirapine (Viramune)",
      "Zidovudine",
      "Abacavir"
    ],
    correct: 2
  },
  {
    question: "Cocher sur linhibiteur de protase",
    img: "",
    responses: [
      "Nvirapine",
      "Ritonavir",
      "Stavudine",
      "Lamivudine",
      "Abacavir"
    ],
    correct: 1
  },
  {
    question: "La voie digestive nest pas toujours utilisable selon la nature du mdicament (cocher sur 1 rponse fausse)",
    img: "",
    responses: [
      "Dgrad par le pH acide de lestomac",
      "Dgrad par les enzymes protolytiques digestives",
      "Irritant ou caustique pour les muqueuse digestive",
      "Non rsorb",
      "Traitement des pathologies hpatiques"
    ],
    correct: 4
  },
  {
    question: "Utilisation per os pour rechercher une action locale (cocher sur 1 rponse fausse)",
    img: "",
    responses: [
      "Pansement",
      "Anti-hmorrodares en suppositoires",
      "Anitparasitaires intestinaux",
      "Anti-spasmodiques",
      "Sufamides intestinaux"
    ],
    correct: 3
  },
  {
    question: "Mdicaments per os ont des actions gnrales (cocher sur 1 rponse fausse)",
    img: "",
    responses: [
      "Rsorbtion buccale",
      "Rsorbtion gastrique",
      "Les antiparasitaires interstinaux",
      "Rsorbtion dans lintestin grle",
      "Rsorbtion par le gros intestin"
    ],
    correct: 2
  },
  {
    question: "Voie intamusculaire (IM) : (cocher sur 1 rponse fausse)",
    img: "",
    responses: [
      "Glucocorticode retartd peut provoquer atrophie musculaire localise",
      "Phnomnes denkystement",
      "Injection des anticoagulants",
      "Moins douleureuse que le voie sous cutane",
      "Possible de prparation huileuses"
    ],
    correct: 2
  },
  {
    question: "Voie transcutan : (cocher sur 1 rponse fausse)",
    img: "",
    responses: [
      "Rsorbtion coustante et rgulire",
      "Mauvaise biodisponibilit",
      "La lsion cutane augmente la rsorbtion des mdicaments",
      "Les dsinfections mercuriels peuvent augmenter la toxicit",
      "Larrt immdiat du mdicament par simple ablation"
    ],
    correct: 1
  },
  {
    question: "Contre-indications de lAmphotricine B (cocher sur 1 rponse fausse)",
    img: "",
    responses: [
      "Insuffisance rnale pr-existance",
      "Raction de hypersensiblit",
      "Risque dassociation dangereuse avec les antiarythmique",
      "La possibilit deffet tratogne",
      "Hpatite"
    ],
    correct: 4
  },
  {
    question: "Le nom commercial de Kroconazole (cocher sur 1 rponse juste)",
    img: "",
    responses: [
      "Daktarin",
      "Nizoral",
      "Sporanox",
      "Triflucan",
      "Flagyl"
    ],
    correct: 1
  },
  {
    question: "Grisofulvine est antifongique pour traiter (cocher sur 1 rponse fausse)",
    img: "",
    responses: [
      "Candida",
      "Crytococcus",
      "Dermatophyte",
      "Aspergillus",
      "Blastomycose"
    ],
    correct: 2
  },
  {
    question: "Lacide utilis pour prserver les aliments (cocher sur 1 rponse juste)",
    img: "",
    responses: [
      "Acide actique",
      "Acide benzoque",
      "Acide chloridrique",
      "Acide borique",
      "Acide lactique"
    ],
    correct: 1
  },
  {
    question: "Les antiseptique et dsinfectant de leau de boisson (cocher sur 1 rponse juste)",
    img: "",
    responses: [
      "Acide actique",
      "Le permanganate de potassium",
      "Chlorramine",
      "Lacide borique",
      "Lacide lactique"
    ],
    correct: 2
  },
  {
    question: "La posologie des mdicaments pour les adultes ? (cocher sur 1 rponse fausse)",
    img: "",
    responses: [
      "Tenant compte de la taille",
      "Tenant compte du poids",
      "Tenant compte dlimination par le foie",
      "Tenant compte dlimination par le rein",
      "Tenant compte du prix"
    ],
    correct: 4
  },
  {
    question: "Adaptation de doses des mdicaments chez le sujet g (cocher sur 1 rponse fausse)",
    img: "",
    responses: [
      " 65 ans 65% de la dose adulte",
      " 80 ans 50% de la dose adulte",
      "Ou calculera la dose  partir de la clairance de la cratinine",
      "Selon le gravit de la maladie",
      "Selon les capacits dlimination"
    ],
    correct: 3
  },
  {
    question: "Adaptation de dose chez lenfant (le nouveau-n): (cocher sur 1 rponse fausse)",
    img: "",
    responses: [
      "Limmaturation enzymatique",
      "Le volume de distribution est diffrent",
      "La clairance rnale est trs faible",
      "Le bilirubine (libre) est trs dangereux pour le systme nerveux central",
      "La perfusion dalumine humaine augmente la fraction libre de la bilirubine"
    ],
    correct: 4
  },
  {
    question: "Adaptation de dose chez lenfant plus de 2 ans (cocher sur 1 rponse juste)",
    img: "",
    responses: [
      "En fonction de pathologie",
      "Rgle de trois  partir de calculer la posologie adulte standard du poids",
      "En fonction de la clairance rnale",
      "Selon le sexe",
      "Selon la taille"
    ],
    correct: 1
  },
  {
    question: "Le nom gnrique ABC",
    img: "",
    responses: [
      "Tnofovir",
      "Stavutine",
      "Abacavir",
      "Didanosine",
      "Lamivudine"
    ],
    correct: 2
  },
  {
    question: "Un medicament de cet groupe est utilis autrefois comme antihpatite B",
    img: "",
    responses: [
      "Stavadine",
      "Lamivudine",
      "Abacavir",
      "Didanosine",
      "Tnofovir"
    ],
    correct: 1
  },
  {
    question: "Le mdicament de groupe NNRTIs.",
    img: "",
    responses: [
      "Nvirapine",
      "Indinavir",
      "Ritonavir",
      "Stavudine",
      "Lamivudine"
    ],
    correct: 0
  },
  {
    question: "Les effets indsirables principaux de groupe inhibiteur de protease.",
    img: "",
    responses: [
      "Troubles de motricit",
      "Troubles sensitive",
      "Lipodystrophie",
      "Troubles neurovgtatives",
      "Troubles de vision"
    ],
    correct: 2
  },
  {
    question: "La shma de traitement le plus lgitime de linfection des Rtro viraux",
    img: "",
    responses: [
      "Lemplou linhibiteur du protease seul",
      "Lassociation NNRTI et NsRTI",
      "Lassociation Ns RTI + Nt RTI + PI",
      "NNRTI seul",
      "Nt RTI seul."
    ],
    correct: 2
  },
  {
    question: "Le nom abbrviation de ritonavir.",
    img: "",
    responses: [
      "ATC",
      "NVP",
      "EFV",
      "NFV",
      "RTV"
    ],
    correct: 4
  },
  {
    question: "Le nouveau antirtroviraux.",
    img: "",
    responses: [
      "litgravir",
      "Stavudine",
      "Lamivudine",
      "Abacavir",
      "Tnofovir"
    ],
    correct: 0
  },
  {
    question: "Le groupe antirtrovireu qui donne une toxication mtochondriale.",
    img: "",
    responses: [
      "IP",
      "NRTIs",
      "Nt RTI",
      "Les groups antirtroviraux nouveaux",
      "NNRTI"
    ],
    correct: 1
  },
  {
    question: "Fonction du medicament",
    img: "",
    responses: [
      "Prventive individuelle",
      "Traitement substitutive",
      "Physiologique",
      "Fonction diagnostique",
      "Traitement symptomatique."
    ],
    correct: 2
  },
  {
    question: "Origine des medicaments.",
    img: "",
    responses: [
      "Origine vgtale",
      "Origine animale",
      "Origine synthtique",
      "Origine biogntique",
      "Origine industrielle"
    ],
    correct: 4
  },
  {
    question: "Dnomination des mdicaments.",
    img: "",
    responses: [
      "Un nom chimiqne",
      "Dnomination commune internationale",
      "Nom de marque",
      "Dnominations communes nationales",
      "Dnominations communes familiales"
    ],
    correct: 4
  },
  {
    question: "Dnomination commune internationales de cet medicament.",
    img: "",
    responses: [
      "Doliprane",
      "Kinal",
      "Paractamol",
      "Sara",
      "Efferalgan"
    ],
    correct: 2
  },
  {
    question: "Origine vgtale de cet medicament.",
    img: "",
    responses: [
      "Quinine",
      "Strychnine",
      "Ginkor giloba",
      "Digoxine",
      "Ampicilline"
    ],
    correct: 4
  },
  {
    question: "Origine animale de cet mdicament",
    img: "",
    responses: [
      "Insuline",
      "Trypsine",
      "Urokinase",
      "Morphine",
      "Chymotrypsine"
    ],
    correct: 3
  },
  {
    question: "Mdicaments gnriques et medicaments de marque (Brand name)",
    img: "",
    responses: [
      "Crestor",
      "Kinal",
      "Esome",
      "Pilokit",
      "Rabirol."
    ],
    correct: 1
  },
  {
    question: "Le taux de lalcoolmie qui provoque le coma (g/l)",
    img: "",
    responses: [
      "0.5- 1",
      "1- 2",
      "2- 3",
      "3- 4",
      "> 5"
    ],
    correct: 3
  },
  {
    question: "Consquence dune consommation chronique de lalcool pour le foie et le tube digestif.",
    img: "",
    responses: [
      "Statose hpatique",
      "Cirrhose",
      "Pancratite",
      "Gastrite",
      "Diarrhe chronique"
    ],
    correct: 4
  },
  {
    question: "Consquence dune consommation chronique de lalcool pour le systme nerveux.",
    img: "",
    responses: [
      "Dpendance physique",
      "Dpendance psychique",
      "Dlirium trmens",
      "Neuropathie priphrique",
      "Hmiplgie."
    ],
    correct: 4
  },
  {
    question: "Consquence dune consummation chronique de lalcool pour le systme endocrine et quilibre hydro letrolytique.",
    img: "",
    responses: [
      "gncomastie",
      "Atrophie testiculaire",
      "Hyperglycmie",
      "Hyperaldostronisme",
      "Hypokalimie."
    ],
    correct: 2
  },
  {
    question: "LEthanol",
    img: "",
    responses: [
      "Alcool mthalique",
      "Est toxique",
      "Alcool thylique",
      "thylne glycol",
      "Estmac plein rtarde son absorbtion."
    ],
    correct: 2
  },
  {
    question: "La formule chimique de lactadhyde.",
    img: "",
    responses: [
      "CH3 CH2 OH",
      "CH3 CHO",
      "CH3 COO-",
      "CO2",
      "CH2 OH"
    ],
    correct: 1
  },
  {
    question: "Les medicaments qui donnent leffet antabuse.",
    img: "",
    responses: [
      "Le Bactrim",
      "Le mtronidazole",
      "La cphalosporine",
      "Le paractamol",
      "Le flagyl"
    ],
    correct: 1
  },
  {
    question: "Les medicaments qui provoqunt la pharmacodpcndance.",
    img: "",
    responses: [
      "Les laxatifs",
      "Salbutamol",
      "Les gluocorticodes",
      "Thiamine",
      "Les tranquilisants"
    ],
    correct: 3
  },
  {
    question: "Les groupes des substances qui provoquent la toxicomanie.",
    img: "",
    responses: [
      "Les hallucinogne",
      "Les nivrants",
      "Les opiac et lcurs drivs",
      "Les excitants",
      "Les myorelaxants"
    ],
    correct: 4
  },
  {
    question: "Les nivrants",
    img: "",
    responses: [
      "Alcool thylique",
      "Lther",
      "Le cannabis",
      "Pthidine",
      "Les solvants organiques."
    ],
    correct: 3
  },
  {
    question: "Les psychotropes.",
    img: "",
    responses: [
      "La morphine",
      "Le cannabis",
      "La piradoxine (vit B6)",
      "Le cocane",
      "Lamphtamine"
    ],
    correct: 2
  },
  {
    question: "La morphine est lextrait de",
    img: "",
    responses: [
      "Cannabis",
      "Pivot",
      "Hrone",
      "Cocaine",
      "Lamphtamine"
    ],
    correct: 1
  },
  {
    question: "Le naloxone est lantidote de",
    img: "",
    responses: [
      "Cannabis",
      "Cocaine",
      "Diazpam",
      "Morphine",
      "Des solvants organiques."
    ],
    correct: 3
  },
  {
    question: "Les morphiniques de synthse",
    img: "",
    responses: [
      "Dolosal",
      "Fantanyl",
      "Eubine",
      "Pancodane",
      "Amphtamine"
    ],
    correct: 4
  },
  {
    question: "La dnomination actuelle des mdicaments",
    img: "",
    responses: [
      "Substances dangereuses",
      "Substances stupfiants",
      "Substances substitutives",
      "Sustances psychotropes",
      "Mdicaments de liste I et II"
    ],
    correct: 2
  },
  {
    question: "Rgles de redaction de lordonnance",
    img: "",
    responses: [
      "Dose, horaire de la prise",
      "Individuelle, ne pas antidat",
      "Lisible, comprise",
      "Emgagement financire",
      "Doit tre imprmer pas de signature du mdecin"
    ],
    correct: 4
  },
  {
    question: "Il est class dans la substance stupfiant",
    img: "",
    responses: [
      "Le laselix",
      "La codeine",
      "Le cannabis",
      "Lthanol",
      "La digoxine"
    ],
    correct: 2
  },
  {
    question: "Le morphine est class daus le tableau",
    img: "",
    responses: [
      "Tableau (A)",
      "Tableau (B)",
      "Tableau (C)",
      "Substances daugereux",
      "Substances psychotropes"
    ],
    correct: 1
  },
  {
    question: "La dure maximale de la prescription de la morphine injectable",
    img: "",
    responses: [
      "7 jours",
      "14 jours",
      "28 jours",
      "1 mois",
      "2 mois."
    ],
    correct: 0
  },
  {
    question: "Dispositions particulires des medicaments  prescription restreinte",
    img: "",
    responses: [
      "Peut acheter danus tous les pharmacie",
      "Peut acheter au pharmacie olympic",
      "Ne ncessite pas dexaminer examen biologique complet",
      "Traitemente ambultoire",
      "Dlivrer par la pharmacie hospitalire"
    ],
    correct: 4
  },
  {
    question: "Les medicaments orphelins",
    img: "",
    responses: [
      "Pour les enfants qui nont pas des parents",
      "Cute trs chers",
      "Rserver dans lhopital publique",
      "Mdicaments ont une importance particulire en pdiatrie prescritent pas les professeurs specialists",
      "Peut acheter dans tous les pharmacies."
    ],
    correct: 3
  },
  {
    question: "Le traitement contre les dermophytes",
    img: "",
    responses: [
      "Fonngizone",
      "Miconazole",
      "Grisofulvine",
      "Fluconazole",
      "Itraconazole."
    ],
    correct: 2
  },
  {
    question: "Antimycosiques employs pour traitement des dandruf (Plicules) de le shampoo",
    img: "",
    responses: [
      "Miconazole",
      "Daktarin",
      "Ketoconazole",
      "Fluconazole",
      "Itraconazole"
    ],
    correct: 2
  },
  {
    question: "Traitement du pityriasis versicolor",
    img: "",
    responses: [
      "Gel daktarin",
      "Mycostatine",
      "Candaole gel",
      "Grisofulvine",
      "Ktoderme."
    ],
    correct: 2
  },
  {
    question: "Les antifongiques imidazols",
    img: "",
    responses: [
      "Miconazole",
      "Ktoconazole",
      "Mtronidazole",
      "Itraconazole",
      "Fluconazole."
    ],
    correct: 2
  },
  {
    question: "Le traitement de mningites  crytococcose aprs le fungizone pour relayer le traitement",
    img: "",
    responses: [
      "Grisofulvine",
      "Fluconazole",
      "Terbinafine",
      "Flucytosine",
      "Ktoconazole"
    ],
    correct: 1
  },
  {
    question: "Antifongique utilis empirique dans le traitement en rhumatologie",
    img: "",
    responses: [
      "Ktoconazole",
      "Fluconazole",
      "Grisofulvine",
      "Terbinafine",
      "Flucytosine"
    ],
    correct: 2
  },
  {
    question: "Le DCI denomination commun international de fungizone",
    img: "",
    responses: [
      "Imidazole",
      "Terbinafine",
      "Amphotricine (B)",
      "Grisofulvine",
      "Flucytosine."
    ],
    correct: 2
  },
  {
    question: "Lacide utilis pour prservr lalimcntatiou de conserv",
    img: "",
    responses: [
      "Lacide actique",
      "Lacide benzoique",
      "Lacide borique",
      "Lacide lactique",
      "Lacide chloridrique"
    ],
    correct: 1
  },
  {
    question: "Substance colore pour dsinfecter les lgumes",
    img: "",
    responses: [
      "Btadine",
      "Chlorcxidine",
      "Permanganate de potassium",
      "Nitrate dargent",
      "Lacide borique"
    ],
    correct: 2
  },
  {
    question: "Substance iode pour dsinfecter la peau et les mucqueuses.",
    img: "",
    responses: [
      "Pormanganate de potassium",
      "Acide actique",
      "Formol",
      "Chloramine",
      "Btadine"
    ],
    correct: 4
  },
  {
    question: "Substance pour prsesver les pices anatomiques pour lexamen anatomopathologique",
    img: "",
    responses: [
      "Acide chloridrique",
      "Btadine",
      "Formol",
      "Chlorexidine",
      "Lacide borique"
    ],
    correct: 2
  },
  {
    question: "Drive des mtaux utiliss comme antiseptique",
    img: "",
    responses: [
      "Chloramine",
      "Ethanol",
      "Le phnol",
      "Nitrate dargent",
      "Acide actique"
    ],
    correct: 3
  },
  {
    question: "Btadine",
    img: "",
    responses: [
      "Alcool + chlore",
      "Alcool + ac borique",
      "Alcool + composs ides",
      "Alcool + nitrate dargent",
      "Alcool + phnol"
    ],
    correct: 2
  },
  {
    question: "Antiseptique provoquant des bulles au contact des plaies",
    img: "",
    responses: [
      "Permanganate de potassium",
      "Teinture diode",
      "Nitrate dargent",
      "Eau oxygn",
      "Acide Benzoique"
    ],
    correct: 3
  },
  {
    question: "La voie la plus pratique et commodit",
    img: "",
    responses: [
      "Intramusculaire",
      "Orale",
      "Intraveineuse",
      "Cutane",
      "Inhalation"
    ],
    correct: 1
  },
  {
    question: "Le choix dune voie dadministration depend",
    img: "",
    responses: [
      "Situation urgence",
      "Volume importance  administer",
      "Action locale",
      "Action gnrale",
      "Qualit du mdicament"
    ],
    correct: 4
  },
  {
    question: "La voie le plus commode pour le traitement dune petite plaie cutane",
    img: "",
    responses: [
      "Intramusculaire",
      "Intraveineuse",
      "Cutane locale",
      "Orale",
      "Inhalation"
    ],
    correct: 2
  },
  {
    question: "La voie la plus utilise en reanimation",
    img: "",
    responses: [
      "Intracardiaque",
      "Cutane",
      "Inhalation",
      "Orale",
      "Intraveinse"
    ],
    correct: 4
  },
  {
    question: "La voie que lon peut domner une grande quantie de liquide dans le choc hypovolumique",
    img: "",
    responses: [
      "Intramusculaire",
      "Intraveineuse priphrique",
      "Voie veineuse sous clavire",
      "Intraveineuse crbrale",
      "Orale"
    ],
    correct: 2
  },
  {
    question: "Les vioes combines utilises dans la chirurgie de lougue dure",
    img: "",
    responses: [
      "Orale et intraveineuse",
      "Inhalation et intramusalaire",
      "Orale et intramusculaire",
      "Intramusculaire et intraveineuse",
      "Inhalation et intraveineuse"
    ],
    correct: 4
  },
  {
    question: "La voie utilie pour traiter les maladies parasitaires intestinales",
    img: "",
    responses: [
      "Voie cutane",
      "Inhalation",
      "Intraveineuse",
      "Orale",
      "Intramusculaire"
    ],
    correct: 3
  },
  {
    question: "Le dose mdicamenteux ideal dun sejet de 84as",
    img: "",
    responses: [
      "65% de la dose adulte",
      "10% de la dose adulte",
      "80% de la dose adulte",
      "50% de la dose adulte",
      "70% de la dose adulte"
    ],
    correct: 3
  },
  {
    question: "La dose de la dopamine pour avoir action diurtique.",
    img: "",
    responses: [
      "7g/ kg / h",
      "10g/ kg / h",
      "5g/ kg / h",
      "20g/ kg / h",
      "30g/ kg / h"
    ],
    correct: 2
  },
  {
    question: "La dose de ceftriaxoue utilis par jour chez un adulte de 40kg atteint de pneumonic.",
    img: "",
    responses: [
      "1g/ J",
      "2g/ J",
      "6g/ J",
      "5g/ J",
      "3g/ J"
    ],
    correct: 1
  },
  {
    question: "La dose rifampicine daus traitement de la tuberculose pulmonaire.",
    img: "",
    responses: [
      "5mg/kg",
      "10mg/kg",
      "15mg/kg",
      "20mg/kg",
      "25mg/kg"
    ],
    correct: 1
  },
  {
    question: "Qul examen pour valuer la dose mdicamenteuse exact pour les personnes ges",
    img: "",
    responses: [
      "Trausaminase",
      "Hmogramme",
      "Clearauce de la cratinine",
      "Ure sauguin",
      "Ionogramme"
    ],
    correct: 2
  },
  {
    question: "La dose maximale de diamicron MR quou peut donner au patient diabtique type II de ladulte.",
    img: "",
    responses: [
      "30mg",
      "60mg",
      "90mg",
      "50mg",
      "120mg"
    ],
    correct: 4
  },
  {
    question: "La dose journalire de la streptomycine (aminoside) chez les adultes",
    img: "",
    responses: [
      "500mg",
      "1g",
      "2g",
      "3g",
      "4g"
    ],
    correct: 1
  },
  {
    question: "Les rcepteurs adrnergiques se trouvent au niveau postsynaptique:",
    img: "",
    responses: [
      "des ganglions sympathiques",
      "des ganglions parasympathiques",
      "des terminaisons sympathiques",
      "des terminaisons parasypmpathiques",
      "des muscles squelettiques"
    ],
    correct: 2
  },
  {
    question: "La dopamine est le produit du catabolisme:",
    img: "",
    responses: [
      "des gonadotrophines",
      "de la vasopressine",
      "des glucocorticoides",
      "de la tyrosine",
      "Aucun"
    ],
    correct: 3
  },
  {
    question: "Le disulfurane est un inhibiteur du catabolisme:",
    img: "",
    responses: [
      "de la tyrosine",
      "du L-dopa",
      "de la dopamine",
      "de la noradrnaline",
      "Tous"
    ],
    correct: 2
  },
  {
    question: "Les organes suivants sont riches en noradrnaline, sauf:",
    img: "",
    responses: [
      "la mdullosurnale",
      "le coeur",
      "les vaisseaux",
      "le cerveau",
      "tous"
    ],
    correct: 0
  },
  {
    question: "Suivant les tapes successifs dans la biognse des cathcholamines, lactivation du catabolisme se fait par hydroxylation, sauf :",
    img: "",
    responses: [
      "la phnylalanine en tyrosine",
      "la tyrosine en L-dopa",
      "la L-dopa en dopamine",
      "la dopamine en noradrnaline",
      "tous"
    ],
    correct: 2
  },
  {
    question: "Suivant les tapes successifs dans la biognse des cathcholamines, linhibition du catabolisme se fait par mthylation, sauf:",
    img: "",
    responses: [
      "la tyrosine en L-dopa",
      "la L-dopa en dopamine",
      "la dopamine en noradrnaline",
      "la noradrnaline en adrnaline",
      "tous"
    ],
    correct: 3
  },
  {
    question: "Lequel des mdicaments suivants est utilis dans lhypotension orthostatique:",
    img: "",
    responses: [
      "Midodrine",
      "ergotamine",
      "naphtazoline",
      "mthylergotamine",
      "Tous"
    ],
    correct: 0
  },
  {
    question: "Lequel de ces mdicaments suivants utilis dans la migraine:",
    img: "",
    responses: [
      "Midodrine",
      "ergotamine",
      "naphtazoline",
      "mthylergotamine",
      "Tous"
    ],
    correct: 1
  },
  {
    question: "Les mdicaments suivants sont utiliss pour le traitement prventif des crises d'asthme, sauf:",
    img: "",
    responses: [
      "Salbutamol: Ventoline* inj amp 5 mg",
      "Salmtrol: Srvent* arosol, poudre pour inhalation",
      "Formotrol: Foradil* arosol, poudre pour inhalation",
      "Bambutrol: Oxol* comp 10-20 mg",
      "Terbutaline: Bricanyl* comp LP 5mg"
    ],
    correct: 0
  },
  {
    question: "Les mdicaments suivants sont utiliss pour le traitement prventif des crises d'asthme, sauf:",
    img: "",
    responses: [
      "Terbutaline: Bricanyl* inj amp 5mg",
      "Salmtrol: Srvent* arosol, poudre pour inhalation",
      "Formotrol: Foradil* arosol, poudre pou inhalation",
      "Bambutrol: Oxol* comp 10-20 mg",
      "Terbutaline: Bricanyl* comp LP 5mg"
    ],
    correct: 0
  },
  {
    question: "Les mdicaments suivants sont utiliss pour le traitement prventif de la bronchopneumopathie chronique obstructive, sauf:",
    img: "",
    responses: [
      "Salbutamol: Ventoline* inj amp 5 mg",
      "Salmtrol: Srvent* arosol, poudre pour inhalation",
      "Formotrol: Foradil* arosol, poudre pou inhalation",
      "Bambutrol: Oxol* comp 10-20 mg",
      "Tous"
    ],
    correct: 0
  },
  {
    question: "Les mdicaments suivants sont utiliss pour le traitement prventif de la bronchopneumopathie chronique obstructive, sauf:",
    img: "",
    responses: [
      "Terbutaline: Bricanyl* inj amp 5mg",
      "Salmtrol: Srvent* arosol, poudre pour inhalation",
      "Formotrol: Foradil* arosol, poudre pou inhalation",
      "Bambutrol: Oxol* comp 10-20 mg",
      "Tous"
    ],
    correct: 0
  },
  {
    question: "Lequel des mdicaments suivants est utilis pour le traitement de menace daccouchement prmatur:",
    img: "",
    responses: [
      "Salbutamol: Ventoline* inj amp 5 mg",
      "Salmtrol: Srvent* arosol, poudre pour inhalation",
      "Formotrol: Foradil* arosol, poudre pou inhalation",
      "Bambutrol: Oxol* comp 10-20 mg",
      "Tous"
    ],
    correct: 0
  },
  {
    question: "Lequel des mdicament suivants est utilis pour le traitement de menace daccouchement prmatur:",
    img: "",
    responses: [
      "Terbutaline: Bricanyl* inj amp 5mg",
      "Salmtrol: Srvent* arosol, poudre pour inhalation",
      "Formotrol: Foradil* arosol, poudre pou inhalation",
      "Bambutrol: Oxol* comp 10-20 mg",
      "Tous"
    ],
    correct: 0
  },
  {
    question: "Lequel des mdicaments suivants est utilis pour le traitement des crises d'asthme :",
    img: "",
    responses: [
      "Salbutamol: Ventoline* pour inhalation",
      "Salmtrol: Srvent* arosol, poudre pour inhalation",
      "Formotrol: Foradil* arosol, poudre pou inhalation",
      "Bambutrol: Oxol* comp 10-20 mg",
      "Tous"
    ],
    correct: 0
  },
  {
    question: "Lequel des mdicaments est utilis pour le traitement des crises d'asthme :",
    img: "",
    responses: [
      "Terbutaline: Bricanyl* pour inhalation",
      "Salmtrol: Srvent* arosol, poudre pour inhalation",
      "Formotrol: Foradil* arosol, poudre pou inhalation",
      "Bambutrol: Oxol* comp 10-20 mg",
      "Tous"
    ],
    correct: 0
  },
  {
    question: "Parmi les mdicaments suivants, lequel agit au niveau des rcepteurs cardiaques:",
    img: "",
    responses: [
      "salbutamol",
      "terbutaline",
      "dobutamine",
      "formotrol",
      "aucun"
    ],
    correct: 2
  },
  {
    question: "Lequel des mdicaments suivants est utilis dans lhmorragie de la dlivrance:",
    img: "",
    responses: [
      "Midodrine",
      "ergotamine",
      "naphtazoline",
      "mthylergotamine",
      "Tous"
    ],
    correct: 3
  },
  {
    question: "Lequel des mdicaments suivants est utilis dans la congestion nasale:",
    img: "",
    responses: [
      "Midodrine",
      "ergotamine",
      "naphtazoline",
      "mthylergotamine",
      "Tous"
    ],
    correct: 2
  },
  {
    question: "Lequel des antihypertenseurs suivants agit galement sur la rnine:",
    img: "",
    responses: [
      "clonidine",
      "alphamethyldopa",
      "1-bloquant",
      "-bloquant",
      "tout"
    ],
    correct: 3
  },
  {
    question: "Lequel des antihypertenseurs suivants est indiqu dans le traitement prventif de langor:",
    img: "",
    responses: [
      "clonidine",
      "alphamthyldopa",
      "1-bloquant",
      "-bloquant",
      "tout"
    ],
    correct: 3
  },
  {
    question: "Lequel des antihypertenseurs suivants est utilis en cas de tachycardie (p.e dans la maladie de Basedow):",
    img: "",
    responses: [
      "clonidine",
      "alphamthyldopa",
      "1-bloquant",
      "-bloquant",
      "tout"
    ],
    correct: 3
  },
  {
    question: "Lequel des antihypertenseurs suivants agit comme un faux mdiateur de la noradrnaline:",
    img: "",
    responses: [
      "clonidine",
      "alphamthyldopa",
      "1-bloquant",
      "-bloquant",
      "aucun"
    ],
    correct: 1
  },
  {
    question: "Lequel des antihypertenseurs suivants agit au niveau des rcepteurs 2-prsynaptiques centraux:",
    img: "",
    responses: [
      "clonidine",
      "alphamthyldopa",
      "1-bloquant",
      "-bloquant",
      "aucun"
    ],
    correct: 1
  },
  {
    question: "Lequel des antihypertenseurs suivants est utilis dans le traitement prventif dans les hmorragies par rupture des varices oesophagiennes:",
    img: "",
    responses: [
      "clonidine",
      "alphamthyldopa",
      "1-bloquant",
      "-bloquant",
      "tout"
    ],
    correct: 3
  },
  {
    question: "Parmi les mdicaments suivants, lequel est utilis dans le traitement des artrites des membres infrieurs:",
    img: "",
    responses: [
      "prasozine",
      "ifenprodil",
      "nicergoline",
      "indoramine",
      "alfazosine"
    ],
    correct: 1
  },
  {
    question: "Parmi les mdicaments suivants, lequel est utilis dans le traitement de lhypotension orthostatique:",
    img: "",
    responses: [
      "prasozine",
      "ifenprodil",
      "nicergoline",
      "indoramine",
      "alfazosine"
    ],
    correct: 0
  },
  {
    question: "Parmi les mdicaments suivants, lequel est utilis dans le traitement de fond de la migraine :",
    img: "",
    responses: [
      "prasozine",
      "ifenprodil",
      "nicergoline",
      "indoramine",
      "alfazosine"
    ],
    correct: 3
  },
  {
    question: "Parmi les mdicaments lequel est utilis dans le traitement des troubles crbraux de la snescence",
    img: "",
    responses: [
      "prasozine",
      "ifenprodil",
      "nicergoline",
      "indoramine",
      "alfazosine"
    ],
    correct: 2
  },
  {
    question: "Les propositions suivantes concernent le -bloquants liposolubles, sauf:",
    img: "",
    responses: [
      "ils ont un effet de premier passage hpatique",
      "ils ont une interaction mdicamenteuse au niveau du foie",
      "ils sont contre-indiqus en cas dinsuffisance hpatique",
      "ils peuvent tre utiliss en cas d'tat dpressif",
      "ils ont une fixation protique leve"
    ],
    correct: 3
  },
  {
    question: "Les propositions suivantes concernent le btabloquants hydrosolubles, sauf:",
    img: "",
    responses: [
      "ils ont deffet de premier passage hpatique",
      "ils sont excrt au niveau du rein",
      "ils sont contre-indiqus en cas dinsuffisance rnale",
      "ils peuvent tre utiliss en cas d'tat dpressif",
      "ils ont une fixation protique faible"
    ],
    correct: 0
  },
  {
    question: "Parmi ces -bloquants non cardioslectifS, lequel possde une activit sympathomimtique intrinsque :",
    img: "",
    responses: [
      "propanolol",
      "Sotalol",
      "Timolol",
      "Pindolol",
      "Aucun"
    ],
    correct: 3
  },
  {
    question: "Ces -bloquants cardioslectifS ne possdent pas une activit sympathomimtique intrinsque, sauf :",
    img: "",
    responses: [
      "propanolol",
      "Sotalol",
      "Timolol",
      "Pindolol",
      "Aucun"
    ],
    correct: 3
  },
  {
    question: "Parmi ces -bloquants cardioslectifS, lequel possde une activit sympathomimtique intrinsque :",
    img: "",
    responses: [
      "Bisoprolol",
      "Mtoprolol",
      "Atnolol",
      "Acbutolol",
      "Aucun"
    ],
    correct: 1
  },
  {
    question: "Ces -bloquants cardioslectifS ne possdent pas une activit sympathomimtique intrinsque, sauf :",
    img: "",
    responses: [
      "Bisoprolol",
      "Mtoprolol",
      "Atnolol",
      "Acbutolol",
      "Aucun"
    ],
    correct: 3
  },
  {
    question: "Lequel des antidpresseurs suivants porte le nom de spcialit LAROXYL*:",
    img: "",
    responses: [
      "doxpine",
      "imipramine",
      "amitriptyline",
      "mapropiline",
      "Aucun"
    ],
    correct: 2
  },
  {
    question: "Lequel des antidpresseurs suivants porte le nom de spcialit QUITAXON*:",
    img: "",
    responses: [
      "doxpine",
      "imipramine",
      "amitriptyline",
      "mapropiline",
      "Aucun"
    ],
    correct: 0
  },
  {
    question: "Lequel des antidpresseurs suivants porte de spcialit TOFRANIL*:",
    img: "",
    responses: [
      "doxpine",
      "imipramine",
      "amitriptyline",
      "mapropiline",
      "Aucun"
    ],
    correct: 1
  },
  {
    question: "Lequel des antidpresseurs suivants porte de spcialit STABLON*:",
    img: "",
    responses: [
      "tianeptine",
      "miansrine",
      "mirtazapine",
      "duloxtine",
      "Aucun"
    ],
    correct: 0
  },
  {
    question: "Lequel des antidpresseurs suivants porte de spcialit NORSET*:",
    img: "",
    responses: [
      "tianeptine",
      "miansrine",
      "mirtazapine",
      "duloxtine",
      "Aucun"
    ],
    correct: 2
  },
  {
    question: "Lequel des mdicaments suivants utiliss en psychiatrie est un psychostimulant:",
    img: "",
    responses: [
      "halopridol",
      "modafinil",
      "mirtazapine",
      "amitriptyline",
      "Aucun"
    ],
    correct: 1
  },
  {
    question: "Laction de mdiateurs chimiques du systme nerveux vgtatif est :",
    img: "",
    responses: [
      "Indpendant de la volont",
      "Dpendant de la volont",
      "Indpendant de lautomatico-volont",
      "Dpendant de lautomatico-volont",
      "Indpendant de systme nerveux central"
    ],
    correct: 0
  },
  {
    question: "Laction de mdiateurs chimiques du systme nerveux vgtatif rgle :",
    img: "",
    responses: [
      "Le rflexe",
      "Les scrtions des glandes endocrines et exocrines",
      "La respiration",
      "Le systme nerveux central",
      "Le systme nerveux somatique"
    ],
    correct: 1
  },
  {
    question: "Le trajet de laction de mdiateurs chimiques du systme sympathique est travers par :",
    img: "",
    responses: [
      "Ses centres bulbo-sacrs",
      "Ses centres thoraco-lombaires",
      "Ses fibres (neurones) prganglionnaires longs",
      "Ses synapses ganglionnaires se trouvant dans la paroi mme des viscres",
      "Ses fibres postganglionnaires trs courts"
    ],
    correct: 1
  },
  {
    question: "Au contraire, le trajet de laction de mdiateurs chimiques du systme sympathique est travers par :",
    img: "",
    responses: [
      "Ses centres bulbo-sacrs",
      "Ses centres thoraco-lombaires",
      "Ses fibres (neurones) prganglionnaires courts",
      "Ses synapses ganglionnaires paravertbraux",
      "Ses fibres postganglionnaires longs"
    ],
    correct: 0
  },
  {
    question: "Le mdiateur chimique des synapses ganglionnaires est lactylcholine, mais ses rcepteurs cholinergiques de :",
    img: "",
    responses: [
      "Type nicotinique",
      "Type adrnergique",
      "Type dopaminergique",
      "Type muscarinique",
      "Types nicotinique et muscarinique"
    ],
    correct: 0
  },
  {
    question: "Lactylcholine est libre :",
    img: "",
    responses: [
      "Dans les terminaisons du parasympathique avec ses rcepteurs tant de type nicotinique",
      "Dans les terminaisons du parasympathique avec ses rcepteurs tant de type muscarinique",
      "Dans les synapses ganglionnaires du systme nerveux autonome avec ses rcepteurs tant de type muscarinique",
      "Dans les plaques motrices avec ses rcepteurs tant de type muscarinique",
      "Dans le systme nerveux central avec les deux types de rcepteurs coexistent"
    ],
    correct: 1
  },
  {
    question: "Dans les terminaisons prsynaptique :",
    img: "",
    responses: [
      "Lactylcholine contenue dans des vsicules",
      "Les cholinestrases contenuent dans des vsicules",
      "La choline contenue dans des vsicules",
      "La co-enzyme (A) contenue dans des vsicules",
      "Lactyl co-enzyme (A) contenue dans des vsicules"
    ],
    correct: 0
  },
  {
    question: "Les effets muscariniques de lactylcholine  faible dose stimulent le parasympathique au niveau des organes effecteurs tels que :",
    img: "",
    responses: [
      "Les effets cardiaques et vasculaires sont laugmentation de la tension artrielle immdiate et fugace",
      "Les effets sur les fibres musculaires lisses des viscres sont la diminution du pristaltisme intestinal",
      "Les effets sur les scrtions sont la diminution des scrtions digestives",
      "Les effets sur lil sont la mydriase",
      "Les effets centraux sont complexes et mal connus"
    ],
    correct: 4
  },
  {
    question: "Les effets nicotiniques de lactylcholine  forte dose stimulent le ganglion synaptique tels que :",
    img: "",
    responses: [
      "Une libration dactylcholine est par les terminaisons du sympathique",
      "Une libration de la noradrnaline est par les terminaisons du parasympathique",
      "Un relchement musculaire est au niveau de la plaque motrice",
      "Les rles des rcepteurs muscariniques et nicotiniques sont faciles  discerner au niveau du systme nerveux central",
      "Une libration dactylcholine est par les terminaisons du parasympathique"
    ],
    correct: 4
  },
  {
    question: "Lactylcholine est le mdiateur chimique :",
    img: "",
    responses: [
      "Des synapses cholinergiques dans le systme nerveux central",
      "Des terminaisons du sympathique",
      "Des terminaisons du systme nerveaux autonome",
      "Des terminaisons du systme nerveaux somatique",
      "Des ganglons et des terminaisons du sympathique"
    ],
    correct: 0
  },
  {
    question: "Lindication thrapeutique de lactylcholine est :",
    img: "",
    responses: [
      "Les applications cliniques gnralises",
      "Utilise en solution extra-oculaire",
      "Pour une mydriase au cours de la chirurgie oculaire",
      "Les applications cliniques limites pour la fugacit daction",
      "Utilise en solution intra-oculaire (peropratoire) pour laction prolonge"
    ],
    correct: 3
  },
  {
    question: "Les cholinomimtiques peuvent sutiliser dans :",
    img: "",
    responses: [
      "Le traitement du glaucome",
      "Lasthme bronchique",
      "Lintoxication par les insecticides organophosphors",
      "Le mal des transports",
      "La prmdication anesthsique"
    ],
    correct: 0
  },
  {
    question: "Lactylcholine :",
    img: "",
    responses: [
      "Produit un myosis passif",
      "Agit sur les rcepteurs muscariniques",
      "Agit sur les rcepteurs alpha 2 adrnergiques",
      "Est indique dans les asthmes",
      "Est contre-indique en cas dhypertrophie prostatique"
    ],
    correct: 1
  },
  {
    question: "Parmi les groupes pharmacologiques suivants, cochez celui qui est contre-indiqu chez lasthmatique :",
    img: "",
    responses: [
      "Les stimulants alpha adrnergiques",
      "Les anticholinestrasiques",
      "Les sympathomimtiques",
      "Les parasympathomimtiques",
      "Les bloquants bta adrnergiques"
    ],
    correct: 1
  },
  {
    question: "La nicotine :",
    img: "",
    responses: [
      "Entrane la polypne",
      "Na pas dune action anxiolytique",
      "Provoque des tremblements  faible dose",
      "Est responsable dune chute de la pression artrielle",
      "Est le composant responsable de la cancrisation des voies respiratoires"
    ],
    correct: 0
  },
  {
    question: "Les anticholinestrasiques rversibles :",
    img: "",
    responses: [
      "Sont les effets essentiellement muscariniques",
      "Ont laction centrale",
      "Ne sont pas indiques dans le traitement symptomatique de la maladie dAlzeimer",
      "Ne sont pas de troubles digestifs",
      "Conduisent  une chute de la concentration dactylcholine"
    ],
    correct: 0
  },
  {
    question: "Le Sarin est :",
    img: "",
    responses: [
      "Lanticholinestrasique rversible",
      "Lanticholinestrasique irrversible",
      "Latropinique",
      "La ganglioplgique",
      "Le curarisant"
    ],
    correct: 1
  },
  {
    question: "Les signes muscariniques danticholinestrasique irrversible sont :",
    img: "",
    responses: [
      "Mydriase",
      "Myosis",
      "Tachycardie",
      "Scheresse de la bouche",
      "Hyposudation"
    ],
    correct: 1
  },
  {
    question: "Les signes nicotiniques danticholinestrasique irrversible sont :",
    img: "",
    responses: [
      "Bradycardie",
      "Chute de la pression artrielle",
      "Tachycardie",
      "Tremblement",
      "Myosis"
    ],
    correct: 2
  },
  {
    question: "Quel est lantispasmodique qui possde des propris atropiniques ?",
    img: "",
    responses: [
      "Papavrine",
      "Mbvrine (Duspatalin)",
      "La Khelline",
      "La Trimbutine (Dbridat)",
      "Le Timonium (Viscralgine)"
    ],
    correct: 4
  },
  {
    question: "Lactivit anticholinergique, source deffet indsirable, peut se rencontrer dans les classes mdicamenteuses suivantes sauf une, indiquer laquelle :",
    img: "",
    responses: [
      "Morphines",
      "Antidpresseurs tricycliques",
      "Neuroleptiques",
      "Antihistaminiques",
      "Antispasmodiques du tube digestif"
    ],
    correct: 0
  },
  {
    question: "Les propositions suivantes concernent les actions que les mdicaments parasympathiques (ou atropiniques) peuvent produire. Laquelle de ces propositions est inexacte ?",
    img: "",
    responses: [
      "Tachycardie",
      "Relaxation de lintestin",
      "Relaxation des bronches",
      "Relaxation du sphincter vsical",
      "Mydriase"
    ],
    correct: 4
  },
  {
    question: "Latropine est un mdicament :",
    img: "",
    responses: [
      "Anticholinestrasique",
      "Actylchonomimtique",
      "Sympatholytique",
      "Anticholinergique",
      "Sympathomimtique"
    ],
    correct: 3
  },
  {
    question: "Latropine exerce tous les effets suivants sauf un, lequel ?",
    img: "",
    responses: [
      "Tachycardie",
      "Bronchodilatation",
      "Rduction du pristaltisme intestinal",
      "Mydriase",
      "Augmente des scrtions digestives"
    ],
    correct: 4
  },
  {
    question: "Parmi les effets secondaires suivants, indiquer celui que lon peut voir avec un mdicament atropinique :",
    img: "",
    responses: [
      "Myosis",
      "Diarrhe",
      "Rtention urinaire",
      "Hypersialorrhe",
      "Hyperscrtion bronchique"
    ],
    correct: 2
  },
  {
    question: "Quel est, parmi les effets suivants, celui qui est susceptible dtre produit par une substance cholinolytique muscarinique ?",
    img: "",
    responses: [
      "Bradycardie",
      "Allongement du temps de conduction auriculo-ventriculaire",
      "Augmentation des scrtions sudorales",
      "Augmentation du diamtre pupillaire",
      "Bronchoconstriction"
    ],
    correct: 1
  },
  {
    question: "Quelle est la contre-indication demploi des cholinolytiques muscariniques ?",
    img: "",
    responses: [
      "Hypertension artrielle",
      "Adnome prostatique",
      "Allaitement",
      "Glaucome  angle ferm",
      "Grossesse"
    ],
    correct: 1
  },
  {
    question: "Chez un malade parkisonien, lArtane :",
    img: "",
    responses: [
      "Facilite la libration de la dopamine",
      "Agit sur les rcepteurs de la dopamine",
      "Agit sur les systmes cholinergiques",
      "Ne peut pas aggraver des troubles cognitifs",
      "Provoque un myosis"
    ],
    correct: 2
  },
  {
    question: "Latropinique :",
    img: "",
    responses: [
      "Est un inhibiteur comptitif des rcepteurs cholinergiques muscariniques",
      "Se traduit par une augmentation du tonus du parasympathique",
      "Provoque une lvation de la tension artrielle",
      "Provoque le myosis",
      "Provoque la bradycardie"
    ],
    correct: 0
  },
  {
    question: "Effet bactricide ?",
    img: "",
    responses: [
      "Diminution de la pouvoir pathogne bactrienne",
      "Ralentissement de la multiplication bactrienne",
      "La mort des bactries",
      "La mort des microbes",
      "Prolongement du temps de la division cellulaire."
    ],
    correct: 2
  },
  {
    question: "Effet bactriostatique",
    img: "",
    responses: [
      "Tuer des bactries",
      "Ralentissement de la multiplication bactrienne",
      "Diminution de la pouvoir pathogne bactrienne",
      "Inhibition de la division cellulaire microbienne",
      "Augmentation de la pouvoir pathogne bactrienne."
    ],
    correct: 1
  },
  {
    question: "La bactrie rsistance peut tre  un antibiotique et stendre  un autre antibiotique dans une mme famille dantibiotiques, on appel :",
    img: "",
    responses: [
      "La rsistance naturelle",
      "La rsistance chromosomique",
      "La rsistance acquise",
      "La rsistance extra-chromosomique",
      "La rsistance croise"
    ],
    correct: 4
  },
  {
    question: "La rsistance dune bactrie: insensibilit demble cest la rsistance despces, on appel :",
    img: "",
    responses: [
      "La rsistance acquise par transfert",
      "La rsistance acquise par mutation",
      "La rsistance extra-chromosomique",
      "La rsistance croise",
      "La rsistance naturelle"
    ],
    correct: 4
  },
  {
    question: "La rsistance dune espce (bactrie) dabord sensible puis devient insensible (aprs augmente brutale de la dose), cest la rsistance ?",
    img: "",
    responses: [
      "La rsistance acquise par mutation",
      "La rsistance extra-chromosomique",
      "La rsistance acquise",
      "La rsistance naturelle",
      "La rsistance croise"
    ],
    correct: 2
  },
  {
    question: "Mcanisme daction: des sulfamides antibactriens agissent par quel mcanisme ?",
    img: "",
    responses: [
      "Interfrence avec le mtabolisme de lacide para-aminobenzoque",
      "Action sur la paroi bactrienne",
      "Action sur la structure de la membrane cytoplasmique",
      "Action sur la synthse protique",
      "Action sur les ribosomes bactriens"
    ],
    correct: 0
  },
  {
    question: "Le sulfamide antibactrien a tait extrait de",
    img: "",
    responses: [
      "un colorant azoque (le PRONTOSIL)",
      "lacide para-aminobenzoque",
      "genre streptomyces",
      "moisissures",
      "des cultures de .B. brevis"
    ],
    correct: 0
  },
  {
    question: "On utilise les Sulfamides non rsorbables pour traiter ?",
    img: "",
    responses: [
      "les infections des voies urinaires",
      "les infections des voies respiratoires",
      "les infections des sphres ORL",
      "la fivre typhode",
      "dsinfectant des voies digestives"
    ],
    correct: 4
  },
  {
    question: "La voie dlimination principale des sulfamides ?",
    img: "",
    responses: [
      "voie sanguine",
      "voie fcale",
      "voie rnale",
      "voie biliaire",
      "voie salivaire"
    ],
    correct: 2
  },
  {
    question: "Les Sulfamides associs ?",
    img: "",
    responses: [
      "Sulfamide + Acide clavulanique",
      "Sulfamide + Trimethoprime",
      "Sulfamide + Sulbactam",
      "Sulfamide + Acide folique",
      "Sulfamide + Tazobactam"
    ],
    correct: 1
  },
  {
    question: "Mcanisme daction: Les bta-lactamines agissent par quel mcanisme ?",
    img: "",
    responses: [
      "Action sur la synthse protique",
      "Interfrence avec le mtabolisme de lacide para-aminobenzoque",
      "Action sur la paroi bactrienne",
      "Action sur la structure de la membrane cytoplasmique",
      "Action sur les ribosomes bactriens"
    ],
    correct: 2
  },
  {
    question: "Parmi les Pnicillines suivantes, quelle est la Pnicillines M ?",
    img: "",
    responses: [
      "la benzyl-pnicilline",
      "lamoxicilline",
      "la phnoxymthyl-pnicilline",
      "la benzathine-pnicilline",
      "la cloxacilline"
    ],
    correct: 4
  },
  {
    question: "Parmi les Pnicillines suivantes, quelle est la Pnicillines antipyocianique ?",
    img: "",
    responses: [
      "Ticarcilline",
      "Ampicilline",
      "Oxacilline",
      "Benzyl-pnicilline",
      "Extancilline"
    ],
    correct: 0
  },
  {
    question: "Lantibiotique aminosidique ne doit pas tre administr avec un curare car il y a risque accru de ?",
    img: "",
    responses: [
      "Somnolence",
      "agitation",
      "dpression respiratoire",
      "hallucination",
      "toxicit cochlovestibulaire."
    ],
    correct: 2
  },
  {
    question: "Une diminution de lefficacit des ttracyclines peut tre observe lors de lassociation avec ?",
    img: "",
    responses: [
      "les diurtiques thiazidiques",
      "un rgime  base de lait et de laitages",
      "les sulfamides",
      "les mthicilline",
      "les mdicaments antifongiques."
    ],
    correct: 1
  },
  {
    question: "Chez la femme enceinte il est contre - indiqu de prescrire ?",
    img: "",
    responses: [
      "les aminosides",
      "la pnicilline .G",
      "la pnicilline .M",
      "la spiramycines",
      "lrythromycine."
    ],
    correct: 0
  },
  {
    question: "Un patient a une insuffisance rnale. Vous voulez lui prescrire de la doxycycline: par apport aux doses et aux intervalles habituels dadministration:",
    img: "",
    responses: [
      "Vous ne modifiez pas la dose mais vous diminuez lintervalle dadministration",
      "Vous diminuez la dose sans modifier lintervalle dadministration",
      "Vous ne modifiez pas la dose mais vous doublez lintervalle dadministration",
      "Vous diminuez la dose de moiti en doublant lintervalle dadministration",
      "Vous ne modifiez ni la dose, ni lintervalle dadministration"
    ],
    correct: 4
  },
  {
    question: "Les aminosides sont caractriss par:",
    img: "",
    responses: [
      "une bonne activit sur les pneumocoques",
      "une bonne absorption digestive",
      "une limination rnale prpondrante",
      "une bonne diffusion mninge",
      "une bonne activit sur les anarobies."
    ],
    correct: 2
  },
  {
    question: "Il est possible dviter les accidents de nphrotoxicit de la gentamicine en vitant ?",
    img: "",
    responses: [
      "la surveillance des taux sriques",
      "ladaptation des doses en fonction du degr dinsuffisance rnale",
      "la correction dune ventuelle dshydratation",
      "Maintien dune diurse importante au moyen de Lasilix",
      "linjection PIV continue  forte dose de la gentamicine"
    ],
    correct: 4
  },
  {
    question: "Chez un individu dont les fonctions rnales sont normales, les atibiotiques suivants peuvent exercer une action nphrotoxique directe mme lorsque leur posologie est normale:",
    img: "",
    responses: [
      "les btalactamines",
      "les licosanides",
      "les macrolides",
      "les aminoglycosides",
      "les cyclines."
    ],
    correct: 3
  },
  {
    question: "Les aminosides sont ototoxiques. Quelle est la structure atteinte, parmi les suivantes ?",
    img: "",
    responses: [
      "loreille moyenne",
      "les nerfs auditifs",
      "les voies auditives",
      "les zones dintgration corticale",
      "la trompe dEustache."
    ],
    correct: 1
  },
  {
    question: "Quel est lantibiotique actif sur la pneumonie  Pneumocystis Jiroveci ?",
    img: "",
    responses: [
      "Gentamycine",
      "Colistine",
      "Pnicilline",
      "Cotrimoxazole",
      "Acide nalidixique."
    ],
    correct: 3
  },
  {
    question: "Parmi les antibactriens suivants, lequel a une bonne diffusion mninge, permettant leur emploi par voie gnrale pour les traitements des mningites purulentes aigus de lenfant ?",
    img: "",
    responses: [
      "Cfotaxime",
      "Gentamycine",
      "Ttracyclines",
      "Kanamycine"
    ],
    correct: 0
  },
  {
    question: "Indiquer lantibiotique prsentant un accident de phototoxicit grave ?",
    img: "",
    responses: [
      "Ofloxacine",
      "Doxycline",
      "Erythromycine",
      "Ampicilline",
      "Cloxacilline."
    ],
    correct: 0
  },
  {
    question: "Un des antibiotiques suivants, laquelle est particulirement indiqu dans le BK.?",
    img: "",
    responses: [
      "Cotrime",
      "Ofloxacine",
      "Cphalosporine",
      "Minocycline",
      "Isoniazide"
    ],
    correct: 4
  },
  {
    question: "Parmi les antibiotiques cits ci-dessous, qui nest jamais actif sur le BK, lequel?",
    img: "",
    responses: [
      "I N H",
      "Pyrazinamide",
      "Dapsone",
      "Rifampicine",
      "Etambutol."
    ],
    correct: 2
  },
  {
    question: "Les accidents cutans ci-dessous sont causs par les sulfamides, quel est celui qui est le plus svre?",
    img: "",
    responses: [
      "Syndrome de StevensJonhson",
      "Syndrome de Lyell",
      "Eruptions cutans scarlatiniforme",
      "Toxidermie",
      "Erythrodermie."
    ],
    correct: 1
  },
  {
    question: "Les antibiotiques suivants quel est peut indiquer en car de mningite bactrienne ?",
    img: "",
    responses: [
      "Sisoline",
      "Rovamycine",
      "Oxyttracycline",
      "Cotrimoxazole",
      "Gentamycine."
    ],
    correct: 3
  },
  {
    question: "Le cotrimoxazole ne doit pas tre admimistr immdiatement aprs une vaccination antittanique, car il y a risque de ?",
    img: "",
    responses: [
      "Aplasie mdullaire",
      "Troubles cochlaire",
      "Colite pseudo membraneuse",
      "Immunodpression",
      "Hpatite cholestatique."
    ],
    correct: 3
  },
  {
    question: "Parmi les macrolides suivants, indiquer celui qui na pas daction inhibitrice enzymatique ?",
    img: "",
    responses: [
      "Spiramycine",
      "Clarithromycine",
      "Erythromycine",
      "Azithromycine",
      "Roxithromycine."
    ],
    correct: 0
  },
  {
    question: "Parmi les macrolides suivants, indiquer celui qui a une particularit daccidents auditifs ?",
    img: "",
    responses: [
      "Azithromycine",
      "Roxithromycine",
      "Erythromycine",
      "Spiramycine",
      "Clarithromycine"
    ],
    correct: 4
  },
  {
    question: "Parmi les macrolides suivants, indiquer celui qui est la plus longue dure daction ?",
    img: "",
    responses: [
      "Erythromycine",
      "Roxithromycine",
      "Azithromycine",
      "Clarithromycine",
      "Spiramycine."
    ],
    correct: 2
  },
  {
    question: "Parmi les antibiotiques suivants, celui qui est actif dans la pneumonie  pneumocystis carinii ?",
    img: "",
    responses: [
      "Pnicilline M",
      "Sulfamide + Trimthoprim",
      "Amikacine",
      "Minocycline",
      "Gentamycine."
    ],
    correct: 1
  },
  {
    question: "Parmi les associations antibiotiques ci-dessous, indiquer celui qui est contre indiquer ?",
    img: "",
    responses: [
      "Ttracycline + Gentalline",
      "Gentamycine + Pnicilline M",
      "Doxycycline + Azithromycine",
      "Clindamycine + Erythromycine",
      "Mtronidazole + Lincomycine."
    ],
    correct: 3
  },
  {
    question: "A quelle famille dantibiotiques appartient la framyctine (Soframycine*) ?",
    img: "",
    responses: [
      "Les sulfamides",
      "Les cyclines",
      "Les aminosides",
      "Les quinolones",
      "Les bta-lactamines."
    ],
    correct: 2
  },
  {
    question: "Lototoxicit (VIIIme paire) est un accident caractristique dune atibiotique, laquelle ?",
    img: "",
    responses: [
      "Gentalline",
      "Colistine",
      "Cphalosporine",
      "Ttracycline",
      "Polymyxine."
    ],
    correct: 0
  },
  {
    question: "Quel est lantibiotique de choix dans le traitement de la nocardiose chez des sujets immunodprims ?",
    img: "",
    responses: [
      "Cotrimoxazole",
      "Gentalline",
      "Terramycine",
      "Spiramycine",
      "Cphalosporine."
    ],
    correct: 0
  },
  {
    question: "Parmi les antibiotiques suivants, quel est celui qui a la meilleure diffusion dans le LCR ?",
    img: "",
    responses: [
      "Staphylomycine",
      "Cphalosporine 1re gnration",
      "Cphalosporine 2me gnration",
      "Cphalosporine 3me gnration",
      "Groupes aminosidiques"
    ],
    correct: 3
  },
  {
    question: "Un des antibiotiques suivants est particulirement indiqu dans les infections par le BK. Laquelle ?",
    img: "",
    responses: [
      "Doxycycline",
      "Cphalosporine",
      "Rifampicine",
      "Carbnicilline",
      "Trobicine"
    ],
    correct: 2
  },
  {
    question: "Parmi les antibiotiques cits ci-dessous, lequel qui nest jamais actif sur les bacilles pyocyaniques ?",
    img: "",
    responses: [
      "Colistine (Colimycine*)",
      "Polymycine .B",
      "Carbnicilline",
      "Cfotaxime",
      "Ampicilline"
    ],
    correct: 4
  },
  {
    question: "Parmi les propositions suivantes, laquelle sapplique le mieux mthicilline ?",
    img: "",
    responses: [
      "Spectre large, rserv au traitement des infections  P. aerusginosa",
      "Spectre large, dtruit par la pnicillinase du staphylocoque",
      "Spectre troit, rsistant  la pnicillinase du staphylocoque",
      "Spectre moyen, sensible  la pnicillinase du staphylocoque",
      "Spectre trs large, rsistant  la pnicillinase du staphylocoque."
    ],
    correct: 2
  },
  {
    question: "Parmi les atibiotiques suivants, indiquer celui qui ne possde pas dactivit antistaphylococcique ?",
    img: "",
    responses: [
      "Ampiciline",
      "Cphalosporine de 1re gnration",
      "Pfloxacine",
      "Pristinamycine (Pyostacine*)",
      "Acide fusidique (Fucidine*)."
    ],
    correct: 0
  },
  {
    question: "La spcialit CLAVENTIN = Ticarcilline+acide clavulanique. Cette association ralise ?",
    img: "",
    responses: [
      "Une synergie additive deffets",
      "Un antagonisme correcteur deffets toxiques",
      "Une augmentation des concentrations plasmatiques dampicilline",
      "Un largissement du spectre antibactrien",
      "Un renforcement defficacit par inhibition des btalactamases bactriennes"
    ],
    correct: 4
  },
  {
    question: "Un seul des antibiotiques peut tre utilis  nimporte quelle priode de la grossesse. Lequel ?",
    img: "",
    responses: [
      "Acide nalidixique",
      "Cotrimoxazole",
      "Pnicilline G",
      "Sulfamides",
      "Ttracyclines."
    ],
    correct: 2
  },
  {
    question: "Un mdicament dont la demi-vie est de 6 heures. Au bout de combien de temps la concentration plasmatique de ce mdicament soit pratiquement nulle aprs larrt du traitement ?",
    img: "",
    responses: [
      "Un jour",
      "30 heures",
      "deux jours",
      "72 heures",
      "quatre jours."
    ],
    correct: 1
  },
  {
    question: "Enfin de traitement dune maladie infection bactrienne, le patient tant guri, quelle est la modalit darrt de lantibiothrapie ?",
    img: "",
    responses: [
      "Rduction progressive des doses",
      "Arrt brutal",
      "Administration discontinue un jour sur deux",
      "Rduction du nombre de prises quotidiennes",
      "Augmentation de la posologie dans les derniers jours."
    ],
    correct: 1
  },
  {
    question: "La pnicilline G est rgulirement active sur ?",
    img: "",
    responses: [
      "Streptocoque du groupe .A",
      "Bacilles .G ( - )",
      ".P. aeruginosa",
      "Mycoplasma pneumoniae",
      "Hmophilus influenzae"
    ],
    correct: 0
  },
  {
    question: "Un adolescent prsent une angine rouge suspecte dorigine streptococcique (groupe A) quel antibiotique le plus mieux adapt ?",
    img: "",
    responses: [
      "Erythromycines",
      "Gentamycine",
      "Cefiximes",
      "Sulfamides",
      "Ciprofloxacine."
    ],
    correct: 0
  },
  {
    question: "Prescrits par voie gnrale certains atibiotiques ne traversent pas ou mal la barrire hmato mninge en cas de mningite et sont donc contre-indiqus. Quel est le plus mieux travers dans le LCR ?",
    img: "",
    responses: [
      "Ampicilline (Totapene*)",
      "Pristinamycine (Pyostacine*)",
      "Vancomycie",
      "Spiramycine (Rovamycine*)",
      "Aminosides"
    ],
    correct: 0
  },
  {
    question: "Les propositions ci-dessous associent un antibiotique et un effet toxique lequel est incorrecte ?",
    img: "",
    responses: [
      "Ciprofloxacine-tendinopathie",
      "Gentamycine-insuffisance rnale",
      "Colistine-hpatite",
      "Vancomycine-insuffisance rnale",
      "Clindamycine- rtinite"
    ],
    correct: 4
  },
  {
    question: "Parmi les antibiotiques ci-dessous, indiquer celui qui est inactif dans tous les cas contre les staphylocoques scrteurs de pnicillinase ?",
    img: "",
    responses: [
      "Mthicilline (Flabelline*)",
      "Ampicilline",
      "Vancomycine (Vancocine*)",
      "Erythromycine",
      "Sisomycine (Sisolline*)"
    ],
    correct: 1
  },
  {
    question: "Parmi les antcdents suivants quel est contre-indiqu de prescrire par Quinolone 3me gnration ?",
    img: "",
    responses: [
      "Insuffisance cardiaque",
      "Insuffisance hpatique",
      "Convulsion",
      "Ulcre gastrique",
      "Infection  VIH."
    ],
    correct: 0
  },
  {
    question: "What is the mechanism of action of morphine?",
    img: "",
    responses: [
      "Acting through binding on G protein couple receptor",
      "Acting through binding on enzyme adenylate cyclase",
      "Acting through binding on exchanger Na  Ca",
      "Acting through binding on tyrosine kinase coupled receptor",
      "Acting through binding on potassium channel"
    ],
    correct: 0
  },
  {
    question: "What second messenger involved in mechanism of action of morphine?",
    img: "",
    responses: [
      "cAMP",
      "cGMP",
      "DAG",
      "IP3",
      "Calmodulin"
    ],
    correct: 0
  },
  {
    question: "What is the effect of AVP on V1 receptor?",
    img: "",
    responses: [
      "Vasoconstriction",
      "ACTH releasing",
      "Reabsorption of water",
      "Reabsorption of Na  Cl",
      "Inhibition post-synaptic potential"
    ],
    correct: 0
  },
  {
    question: "What is the effect of AVP on V2 receptor?",
    img: "",
    responses: [
      "Vasoconstriction",
      "ACTH releasing",
      "Reabsorption of water",
      "Reabsorption of Na  Cl",
      "Activation post-synaptic potential"
    ],
    correct: 2
  },
  {
    question: "Digoxin acts on what of the following transporters?",
    img: "",
    responses: [
      "Na  K ATPases pump",
      "H  K ATPases pump",
      "Co-transport Na  K  2Cl",
      "Na  Ca exchanger",
      "Co-transport Na  Cl"
    ],
    correct: 0
  },
  {
    question: "Digoxin achieves its effect through binding what type of the following transporters?",
    img: "",
    responses: [
      "Primary transport active",
      "Secondary transport active",
      "Simple diffusion",
      "Facilitated diffusion",
      "Anion exchange"
    ],
    correct: 0
  },
  {
    question: "Omeprazole acts on what of the following transporters?",
    img: "",
    responses: [
      "Na  K ATPases pump",
      "H  K ATPases pump",
      "Co-transport Na  K  2Cl",
      "Na  Ca exchanger",
      "Co-transport Na  Cl"
    ],
    correct: 1
  },
  {
    question: "Omeprazole achieves its effect through binding what type of the following transporters?",
    img: "",
    responses: [
      "Primary transport active",
      "Secondary transport active",
      "Simple diffusion",
      "Facilitated diffusion",
      "Anion exchange"
    ],
    correct: 0
  },
  {
    question: "THIAZIDES acts on what of the following transporters?",
    img: "",
    responses: [
      "Na  K ATPases pump",
      "H  K ATPases pump",
      "Na  Ca exchanger",
      "HCO3-  Cl exchanger",
      "Co-transport Na  Cl"
    ],
    correct: 4
  },
  {
    question: "Loop diuretics achieves its effect through binding what type of the following transporters?",
    img: "",
    responses: [
      "Primary transport active",
      "Secondary transport active",
      "Simple diffusion",
      "Facilitated diffusion",
      "Anion exchange"
    ],
    correct: 1
  },
  {
    question: "Furosemide acts on what of the following transporters?",
    img: "",
    responses: [
      "H  K ATPases pump",
      "Na  K ATPases pump",
      "Co-transport Na  K  2Cl",
      "Na  Ca exchanger",
      "Co-transport Na  Cl"
    ],
    correct: 1
  },
  {
    question: "Amlodipine (CCB) achieves its effect through binding what type of the following transporters?",
    img: "",
    responses: [
      "Primary transport active",
      "Secondary transport active",
      "Simple diffusion",
      "Facilitated diffusion",
      "Anion exchange"
    ],
    correct: 2
  },
  {
    question: "Amlodipine acts on what of the following transporters?",
    img: "",
    responses: [
      "L-type voltage calcium channel",
      "T-type voltage calcium Channel",
      "K dependent calcium channel",
      "Ca ATPases pump",
      "Na  Ca exchanger"
    ],
    correct: 0
  },
  {
    question: "Amiloride acts on what of the following transporters?",
    img: "",
    responses: [
      "Na  K ATPases pump",
      "Na  Ca exchanger",
      "HCO3-  Cl exchanger",
      "Renal outer medullary K channel (ROMK)",
      "Epithelial Na channel (ENaC)"
    ],
    correct: 4
  },
  {
    question: "Triamterene acts on what of the following transporters?",
    img: "",
    responses: [
      "Primary transport active",
      "Cation exchange",
      "Simple diffusion",
      "Facilitated diffusion",
      "Anion exchange"
    ],
    correct: 2
  },
  {
    question: "Aldosterone achieves its effect through what mechanism?",
    img: "",
    responses: [
      "Binding to intracellular receptor of principle cell of renal tubule",
      "Activating Na  K channels",
      "Activating carbonic anhydrase",
      "Inhibiting converting enzyme",
      "Producing sodium  glucose transporter 2"
    ],
    correct: 0
  },
  {
    question: "Effect of aspirin acts through what mechanism?",
    img: "",
    responses: [
      "Inhibiting COX1 and COX2",
      "Inhibiting ACE",
      "Opening K channels for hyperpolarization",
      "Binding to ionotropic receptor of Na+ channel",
      "Binding to metabotropic receptor"
    ],
    correct: 0
  },
  {
    question: "Aspirin acts on what of the following enzymes?",
    img: "",
    responses: [
      "Cyclooxygenase",
      "Phosphodiesterase",
      "Converting enzyme",
      "Carbonic anhydrase",
      "Phospholipase"
    ],
    correct: 0
  },
  {
    question: "Sildenafil acts trough what mechanism?",
    img: "",
    responses: [
      "Activating Carbonic anhydrase",
      "Activating aromatase",
      "Inhibiting PDE5",
      "Inhibiting cholinesterase",
      "Inhibiting LOX"
    ],
    correct: 2
  },
  {
    question: "Theophylline acts trough what mechanism?",
    img: "",
    responses: [
      "Inhibiting COX1 and COX2",
      "Inhibiting 5 reductase",
      "Inhibiting PDE 3",
      "Inhibiting cholinesterase",
      "Activating LOX"
    ],
    correct: 2
  },
  {
    question: "Physostigmine act on what enzyme?",
    img: "",
    responses: [
      "Cholinesterase",
      "Lipoxygenase",
      "Cyclooxygenases",
      "Aromatase",
      "Reductase"
    ],
    correct: 0
  },
  {
    question: "Finasteride act on what enzyme?",
    img: "",
    responses: [
      "Cholinesterase",
      "Lipoxygenase",
      "Cyclooxygenases",
      "Aromatase",
      "Reductase"
    ],
    correct: 4
  },
  {
    question: "Exemestane act on what enzyme?",
    img: "",
    responses: [
      "Carbonic anhydrase",
      "Phospholipase",
      "Cyclooxygenases",
      "Aromatase",
      "Reductase"
    ],
    correct: 3
  },
  {
    question: "Calcium channel blocker acts through what mechanism?",
    img: "",
    responses: [
      "Block Na  Ca exchanger",
      "Block voltage dependent calcium channel",
      "Block Ca ATPase pump",
      "Block calcium dependent potassium channel",
      "Activate inactive gate of calcium channel"
    ],
    correct: 1
  },
  {
    question: "What is the constant of dissociation of a drug Kd from its target?",
    img: "",
    responses: [
      "Kd = Koff/Kon",
      "Kd = Kon/Koff",
      "Kd = Kon + Koff",
      "Kd = Kon  Koff",
      "Kd = Koff  Kon"
    ],
    correct: 0
  },
  {
    question: "What quality of drug is to be said high affinity to its target?",
    img: "",
    responses: [
      "rate of dissociation [Kd] is low",
      "rate of dissociation [Kd] is medium",
      "rate of dissociation [Kd] is high",
      "rate of dissociation [Kd] is very high",
      "rate of dissociation [Kd] is indefinite"
    ],
    correct: 0
  },
  {
    question: "Owing to Kd = dissociation constant; R = Total receptor. Formulate law mass action indicating the interaction between Drug  Receptor (D  R)",
    img: "",
    responses: [
      "D-R = ([R] x [D]) + ([D] + Kd)",
      "D-R = ([R] x [D]) x ([D] + Kd)",
      "D-R = ([R] x [D]) - ([D] + Kd)",
      "D-R = ([R] x [D]) / ([D] + Kd)",
      "D-R = ([R] + [D]) / ([D] x Kd)"
    ],
    correct: 3
  },
  {
    question: "What is the signification of dissociation constant Kd?",
    img: "",
    responses: [
      "Concentration of drug capable of binding 50% of the total receptors",
      "Concentration of drug capable of binding 100% of the total receptors",
      "Concentration of drug capable of dissociate from receptors by 20%",
      "Concentration of drug capable of dissociate from receptors by 80%",
      "Concentration of drug capable of dissociate totally from receptors"
    ],
    correct: 0
  },
  {
    question: "Which of the following formula is correct concerning affinity of drug (Kd = dissociation constant)?",
    img: "",
    responses: [
      "Affinity of a drug = 1/Kd",
      "Affinity of a drug = Kd/1",
      "Affinity of a drug = 1 x Kd",
      "Affinity of a drug = 1 + Kd",
      "Affinity of a drug = Kd  1"
    ],
    correct: 0
  },
  {
    question: "What is the meaning of EC50?",
    img: "",
    responses: [
      "Drug concentration gives rise to efficacity 50%",
      "Drug concentration gives rise to efficacity maximum",
      "Drug concentration gives rise to efficacity optimum",
      "Drug concentration gives rise to efficacity in one half life",
      "One half-life gives rise to efficacy 50%"
    ],
    correct: 0
  },
  {
    question: "What properties of a drug is to be said full agonist?",
    img: "",
    responses: [
      "Affinity to receptor with inverse response",
      "Affinity to receptor with no response",
      "Affinity to receptor with submaximal response",
      "Low affinity to receptor with no response",
      "Affinity to receptor with high maximal response"
    ],
    correct: 4
  },
  {
    question: "What properties of a drug is to be said antagonist?",
    img: "",
    responses: [
      "Affinity to receptor with maximal response",
      "High affinity to receptor with no response",
      "Affinity to receptor with submaximal response",
      "Low affinity to receptor with no response",
      "Low affinity to receptor with high response"
    ],
    correct: 1
  },
  {
    question: "What properties of a drug is to be said inverse agonist?",
    img: "",
    responses: [
      "Low affinity to receptor with maximal response",
      "High affinity to receptor with no response",
      "High affinity to receptor with submaximal response",
      "Low affinity to receptor with no response",
      "Affinity to receptor with inverse response"
    ],
    correct: 4
  },
  {
    question: "When partial agonist drug is given with full agonist drug, what is the dynamic interaction as a result?",
    img: "",
    responses: [
      "synergic",
      "additive",
      "competitive",
      "inverse",
      "permissive"
    ],
    correct: 2
  },
  {
    question: "What is the property of a drug with full agonist and low potency?",
    img: "",
    responses: [
      "EC50 high + response maximal",
      "EC50 low + response maximal",
      "EC50 high + response submaximal",
      "EC50 low + response submaximal",
      "EC50 high + response inverse"
    ],
    correct: 0
  },
  {
    question: "What is the property of a drug with full agonist and high potency?",
    img: "",
    responses: [
      "EC50 high + response maximal",
      "EC50 low + response maximal",
      "EC50 high + response submaximal",
      "EC50 low + response submaximal",
      "EC50 low + response inverse"
    ],
    correct: 1
  },
  {
    question: "What is the property of a drug with partial agonist but high potency?",
    img: "",
    responses: [
      "EC50 high + response maximal",
      "EC50 low + response maximal",
      "EC50 high + response submaximal",
      "EC50 low + response submaximal"
    ],
    correct: 3
  },
  {
    question: "What is the property of a drug with full agonist but low potency?",
    img: "",
    responses: [
      "EC50 high + response maximal",
      "EC50 low + response maximal",
      "EC50 high + response submaximal",
      "EC50 low + response submaximal"
    ],
    correct: 0
  },
  {
    question: "Define inverse agonist",
    img: "",
    responses: [
      "affinity to receptor with maximal response",
      "affinity to receptor with inverse response",
      "affinity to receptor with no response",
      "affinity to receptor with partial response",
      "No affinity to receptor with inverse response"
    ],
    correct: 1
  },
  {
    question: "Aspirin is a weak acid with pK3. What pH in the stomach Aspirin would be absorbed 50%?",
    img: "",
    responses: [
      "1",
      "2",
      "3",
      "4",
      "5"
    ],
    correct: 2
  },
  {
    question: "Aspirin is a weak acid with pK3. What pH in the stomach Aspirin would be highly absorbed?",
    img: "",
    responses: [
      "1",
      "2",
      "3",
      "4",
      "5"
    ],
    correct: 0
  },
  {
    question: "Amphetamine is weak base with pK3. What pH in the intestine, it would be absorbed 50%?",
    img: "",
    responses: [
      "1",
      "2",
      "3",
      "4",
      "5"
    ],
    correct: 2
  },
  {
    question: "Amphetamine is weak base with pK3. What pH in the intestine, it would be highly absorbed?",
    img: "",
    responses: [
      "2",
      "3",
      "4",
      "5",
      "6"
    ],
    correct: 4
  },
  {
    question: "What is the distribution volume of a drug given 500mg iv with its plasma concentration 25mg/L at steady state?",
    img: "",
    responses: [
      "5L",
      "10L",
      "15L",
      "20L",
      "30L"
    ],
    correct: 3
  },
  {
    question: "What is the loading dose of a drug with volume distribution 20L and its plasma concentration required at steady state is 25 mg/L?",
    img: "",
    responses: [
      "200 mg",
      "400 mg",
      "500 mg",
      "600 mg",
      "800 mg"
    ],
    correct: 2
  },
  {
    question: "What is the property of a drug with large volume distribution?",
    img: "",
    responses: [
      "Macromolecule",
      "High affinity to serum albumin",
      "Hydrophilic",
      "Lipophilic",
      "Amphoteric"
    ],
    correct: 3
  },
  {
    question: "What is the property of a drug with small volume distribution?",
    img: "",
    responses: [
      "Macromolecule",
      "High affinity to serum albumin",
      "Hydrophilic",
      "Lipophilic",
      "Amphoteric"
    ],
    correct: 1
  },
  {
    question: "What pathway of administration of drug result in bioavailability 100%?",
    img: "",
    responses: [
      "IV",
      "IM",
      "PO",
      "Subcutaneous",
      "Inhalation"
    ],
    correct: 0
  },
  {
    question: "What is the formula for bioavailability of drug? AUC area under curve",
    img: "",
    responses: [
      "AUC iv/AUC po x 100",
      "AUC po/AUC iv x 100",
      "AUC po/AUC iv /100",
      "AUC iv/AUC po/100",
      "AUC po/AUC iv + 100"
    ],
    correct: 1
  },
  {
    question: "Which of the following metabolisms is used in biotransformation (phase 1) in the liver?",
    img: "",
    responses: [
      "Sulfation",
      "Acetylation",
      "Glucuronidation",
      "Hydrolysis",
      "Methylation"
    ],
    correct: 3
  },
  {
    question: "Which of the following metabolisms is used to conjugate (phase 2) a metabolite in the liver?",
    img: "",
    responses: [
      "Oxidation",
      "Hydroxylation",
      "Hydrolysis",
      "Acetylation",
      "Deamination"
    ],
    correct: 3
  },
  {
    question: "Which drug is excreted with zero order kinetic?",
    img: "",
    responses: [
      "acetaminophen",
      "aspirin",
      "rifampicin",
      "cimetidine",
      "atropine"
    ],
    correct: 1
  },
  {
    question: "Which drug is excreted with zero order kinetic?",
    img: "",
    responses: [
      "acetaminophen",
      "alcohol",
      "rifampicin",
      "cimetidine",
      "atropine"
    ],
    correct: 1
  },
  {
    question: "What is the formula of plasma centration of drug at any time (CT) during elimination? C: initial concentration; Ke constant of elimination; T: time",
    img: "",
    responses: [
      "CT = C.e",
      "CT = C x",
      "CT = C /",
      "CT = C ",
      "CT = C +"
    ],
    correct: 0
  },
  {
    question: "Formulate half-life T1/2 related to rate of elimination Ke?",
    img: "",
    responses: [
      "T1/2=ln2/Ke",
      "T1/2=ln2 x Ke",
      "T1/2 = Ke/ln2",
      "T1/2= ln2 + Ke",
      "T1/2= ln2  Ke"
    ],
    correct: 0
  },
  {
    question: "Relate elimination constant (Ke) to clearance (CL) and distribution volume (Vd) of drug?",
    img: "",
    responses: [
      "Ke = CL/Vd",
      "Ke = Vd/CL",
      "Ke = Vd + CL",
      "Ke = Vd x CL",
      "Ke = Vd  CL"
    ],
    correct: 0
  },
  {
    question: "What is the haft life of a drug with constant elimination Ke 1/10?",
    img: "",
    responses: [
      "4h",
      "5h",
      "7h",
      "8h",
      "10h"
    ],
    correct: 2
  },
  {
    question: "How many haft lives of drug we administrate to get its plasma concentration at steady state?",
    img: "",
    responses: [
      "2",
      "3",
      "4",
      "5",
      "6"
    ],
    correct: 3
  },
  {
    question: "How many haft lives of drug the kidney should clear it totally from the body?",
    img: "",
    responses: [
      "2",
      "3",
      "4",
      "5",
      "6"
    ],
    correct: 3
  },
  {
    question: "Give the equation for maintenance dose?",
    img: "",
    responses: [
      "D = distribution volume x effective plasma concentration",
      "D = Clearance x effective plasma concentration",
      "D = Clearance/effective plasma concentration",
      "D = distribution volume /effective plasma concentration",
      "D = distribution volume + effective plasma concentration"
    ],
    correct: 1
  },
  {
    question: "Interaction of Tetracycline with Aluminum is done through what process?",
    img: "",
    responses: [
      "Inactivating P glycoprotein",
      "chelation",
      "deconjugation",
      "competition for organic anion transport",
      "competition for organic cation transport"
    ],
    correct: 1
  },
  {
    question: "Interaction of probenecid administrated with cephalosporin is done through what process?",
    img: "",
    responses: [
      "Inactivating P glycoprotein",
      "Activating Cytochrome P450",
      "Displacing from Albumin",
      "Competition for organic Anion Transporter",
      "Competition for Agonic site of receptor"
    ],
    correct: 3
  },
  {
    question: "Interaction of Digoxin combined with Quinidine is done through what process?",
    img: "",
    responses: [
      "Inactivating P glycoprotein",
      "Activating Cytochrome P450",
      "Displacing from Albumin",
      "Competition for organic Anion Transporter",
      "Binding to Allosteric site of receptor"
    ],
    correct: 0
  },
  {
    question: "What is the management to avoid interaction of rifampicin with warfarin?",
    img: "",
    responses: [
      "give one drugs on hour before another",
      "adjust dose of affected drug after INR",
      "decrease dose of precipitant drug",
      "avoid concurrent therapy",
      "Change formula of one drug"
    ],
    correct: 1
  },
  {
    question: "Interaction of Warfarin combined with cimetidine is done through what process?",
    img: "",
    responses: [
      "Activating P glycoprotein",
      "Inactivating Cytochrome P450",
      "Displacing from Albumin",
      "Competition for organic Anion Transporter",
      "Binding to Allosteric site of receptor"
    ],
    correct: 1
  },
  {
    question: "What is the effect of NSAID + Warfarin?",
    img: "",
    responses: [
      "hyper coagulation",
      "hypo coagulation",
      "increased inflammation",
      "decreased inflammation",
      "thrombocytopenia"
    ],
    correct: 1
  },
  {
    question: "What is the management to interaction of interaction cimetidine  warfarin?",
    img: "",
    responses: [
      "increase dose of warfarin",
      "checkup INR",
      "give another anti secretion acid",
      "avoid concurrent therapy",
      "decrease dose of cimetidine"
    ],
    correct: 2
  },
  {
    question: "What combination should be avoided in a patient with ischemic heart disease?",
    img: "",
    responses: [
      "sildenafil + nitrate",
      "sildenafil +  blocker",
      "Prostaglandin + nitrate",
      "Prostaglandin + blocker",
      "CCB +  blocker"
    ],
    correct: 0
  },
  {
    question: "What cause the adverse effect of fat-soluble drug in elderly person?",
    img: "",
    responses: [
      "slow gastric emptying",
      "decreased volume distribution",
      "increased volume distribution",
      "increased hepatic clearance",
      "increased renal clearance"
    ],
    correct: 2
  },
  {
    question: "What cause the adverse effect of water-soluble drug in elderly person?",
    img: "",
    responses: [
      "slow gastric emptying",
      "decreased volume distribution",
      "increased volume distribution",
      "increased hepatic clearance",
      "increased renal clearance"
    ],
    correct: 1
  },
  {
    question: "What metabolic pathway of drug is preferred to the elderly person?",
    img: "",
    responses: [
      "reduction",
      "oxidation",
      "alkylation",
      "glucuronidation",
      "acetylation"
    ],
    correct: 3
  },
  {
    question: "Define mutation",
    img: "",
    responses: [
      "order sequence of A-G-T-C",
      "change in the base sequence",
      "Transcription error of the base sequence",
      "Translation error of the messenger RNA",
      "Degeneration of protein"
    ],
    correct: 1
  },
  {
    question: "Define Gene",
    img: "",
    responses: [
      "order sequence of A-G-T-C",
      "change in the base sequence",
      "Transcription error of the base sequence",
      "Translation error of the messenger RNA",
      "Degeneration of protein"
    ],
    correct: 0
  },
  {
    question: "Define polymorphism",
    img: "",
    responses: [
      "order of the base sequence",
      "change in the base sequence",
      "alternative of the base sequence",
      "multiple of messenger RNA",
      "repeated base sequence"
    ],
    correct: 2
  },
  {
    question: "What are the components of base sequence?",
    img: "",
    responses: [
      "A  G  T  C",
      "A  B  C  D",
      "G  H  I  J",
      "T  U  V  X",
      "C  D  E  F"
    ],
    correct: 0
  },
  {
    question: "What is single nucleotide polymorphism?",
    img: "",
    responses: [
      "substitution of one nucleotide for another",
      "change the sequence of nucleotides",
      "loss one nucleotide",
      "gain one nucleotide",
      "repeated of one nucleotide"
    ],
    correct: 0
  },
  {
    question: "What is the common substitution of nucleotide in polymorphism?",
    img: "",
    responses: [
      "C for T",
      "G for A",
      "T for C",
      "A for G",
      "G for T"
    ],
    correct: 0
  },
  {
    question: "What is the result of polymorphism for an individual to response to a drug?",
    img: "",
    responses: [
      "same drug with same response in different individuals",
      "same drug with different responses in an individual",
      "same drug with different responses in different individuals",
      "different drugs have the same response in an individual",
      "different drugs have different response in different individuals"
    ],
    correct: 2
  },
  {
    question: "Poor acetylation may alter metabolism of what drugs?",
    img: "",
    responses: [
      "INH",
      "Steroid",
      "Aspirin",
      "Acetaminophen",
      "Rifampicin"
    ],
    correct: 0
  },
  {
    question: "Poor acetylation may alter metabolism of what drugs?",
    img: "",
    responses: [
      "phenytoin",
      "Steroid",
      "Aspirin",
      "Acetaminophen",
      "Rifampicin"
    ],
    correct: 0
  },
  {
    question: "Poor acetylation may alter metabolism of what drugs?",
    img: "",
    responses: [
      "hydralazine",
      "Steroid",
      "Aspirin",
      "Acetaminophen",
      "Rifampicin"
    ],
    correct: 0
  },
  {
    question: "Poor metabolism to convert codeine to morphine require how dose of codeine?",
    img: "",
    responses: [
      "higher",
      "normal",
      "normal low",
      "normal high",
      "lower"
    ],
    correct: 0
  },
  {
    question: "Explain what mitochondria DNA mutation give rise to gentamycin ototoxicity?",
    img: "",
    responses: [
      "hair cells sharing properties with bacteria ribosome",
      "increased plasma level of gentamycin",
      "decreased excretion of gentamycin",
      "alteration of gentamycin metabolism",
      "low affinity to gentamycin"
    ],
    correct: 0
  },
  {
    question: "What polymorphism gene that relate to affinity of warfarin?",
    img: "",
    responses: [
      "CYP2C9",
      "VKORC1",
      "CYP2D6",
      "CYP3A4",
      "CYP2D7"
    ],
    correct: 1
  },
  {
    question: "What polymorphism gene that relate to warfarin metabolism?",
    img: "",
    responses: [
      "CYP2C9",
      "VKORC1",
      "CYP2D6",
      "CYP2D7",
      "CYP3A4"
    ],
    correct: 0
  },
  {
    question: "What polymorphism gene that relate to tamoxifen metabolism?",
    img: "",
    responses: [
      "CYP2C9",
      "VKORC1",
      "CYP2D6",
      "CYP3A4",
      "HLAB*5701"
    ],
    correct: 0
  },
  {
    question: "What HLA gene that related to susceptibility of abacavir?",
    img: "",
    responses: [
      "HLAB*5701",
      "HLA*1502",
      "HLA-DQB10*201",
      "HLA-DQB*05",
      "HLA-DBQ*06"
    ],
    correct: 0
  },
  {
    question: "What HLA gene that related to Stevens Johnson syndrome with carbamazepine?",
    img: "",
    responses: [
      "HLAB*5701",
      "HLA*1502",
      "HLA-DQB1*0201",
      "HLA-DQB*05",
      "HLA-DBQ*06"
    ],
    correct: 1
  },
  {
    question: "What HLA gene that related to agranulocytosis with carbamazepine?",
    img: "",
    responses: [
      "HLAB*5701",
      "HLA*1502",
      "HLA-DQB1*0201",
      "HLA-DQB*05",
      "HLA-DBQ*06"
    ],
    correct: 2
  },
  {
    question: "What Enzyme deficiency related to gene mutation  bone toxicity by thiopurines?",
    img: "",
    responses: [
      "DPYD",
      "TPMT",
      "Xanthine oxidase",
      "G6PD",
      "Cholinesterase"
    ],
    correct: 1
  },
  {
    question: "What Enzyme deficiency due to gene mutation  interaction thiopurine with allopurinol?",
    img: "",
    responses: [
      "DPYD",
      "TPMT",
      "Xanthine oxidase",
      "G6PD",
      "Cholinesterase"
    ],
    correct: 2
  },
  {
    question: "What Enzyme deficiency related to gene mutation  hemolysis?",
    img: "",
    responses: [
      "DPYD",
      "TPMT",
      "Xanthine oxidase",
      "G6PD",
      "Cholinesterase"
    ],
    correct: 3
  },
  {
    question: "What Enzyme detoxify 5FU?",
    img: "",
    responses: [
      "DPYD",
      "TPMT",
      "Xanthine oxidase",
      "G6PD",
      "Cholinesterase"
    ],
    correct: 0
  },
  {
    question: "What cytochrome involved in interaction of warfarin and phenobarbital?",
    img: "",
    responses: [
      "CYP2C9",
      "CYP2D6",
      "CYP3A4",
      "CYP3A5",
      "CYP2D7"
    ],
    correct: 0
  },
  {
    question: "What cytochrome involved in interaction of erythromycin and phenobarbital?",
    img: "",
    responses: [
      "CYP2C9",
      "CYP2C10",
      "CYP2D6",
      "CYP2D7",
      "CYP3A4/5"
    ],
    correct: 4
  },
  {
    question: "What cytochrome involved in interaction of verapamil and rifampicin?",
    img: "",
    responses: [
      "CYP2C9",
      "CYP2C10",
      "CYP2D6",
      "CYP2D7",
      "CYP3A4/5"
    ],
    correct: 4
  },
  {
    question: "What cytochrome involved in metabolism of imipramine?",
    img: "",
    responses: [
      "CYP2C9",
      "CYP2C10",
      "CYP2D7",
      "CYP2D6",
      "CYP3A4/5"
    ],
    correct: 3
  }








    
    ],
    memoriesList: [], // Stores indices of questions from the main bank
    testQuestions: [],
    answers: [],
    currentTestConfig: {},
    idx: 0,
    quizTitle: "Multiple Choice Question Preparation",
    editIdx: -1,
    editQ: null,
    isMuted: true,
    dark: window.matchMedia && window.matchMedia('(prefers-color-scheme: dark)').matches,
    timerId: null,
  };
}
let state = getDefaultState();

// --- Utility & Data Functions ---
function saveData() {
  localStorage.setItem(MEMORY_LIST_KEY, JSON.stringify(state.memoriesList));
}
function loadData() {
  try {
    const memoryData = JSON.parse(localStorage.getItem(MEMORY_LIST_KEY));
    if (memoryData) {
      state.memoriesList = memoryData;
    }
    const settings = JSON.parse(localStorage.getItem(SETTINGS_KEY));
    if (settings) {
        state.dark = settings.dark || false;
        state.isMuted = settings.isMuted === undefined ? true : settings.isMuted;
    }
  } catch (e) {
    console.error("Failed to load data from localStorage", e);
  }
}
function saveSettings() {
    localStorage.setItem(SETTINGS_KEY, JSON.stringify({ dark: state.dark, isMuted: state.isMuted }));
}
function shuffle(arr) {
  const a = arr.slice();
  for(let i = a.length - 1; i > 0; i--) {
    const j = Math.floor(Math.random() * (i + 1));
    [a[i], a[j]] = [a[j], a[i]];
  }
  return a;
}
function escapeHtml(str) {
    if (typeof str !== 'string') return '';
    const brPlaceholder = '___BR___';
    let tempStr = str.replace(/<br\s*\/?>/gi, brPlaceholder);
    tempStr = tempStr.replace(/[&<>"']/g, t => ({
        '&': '&amp;', '<': '&lt;', '>': '&gt;', '"': '&quot;', "'": '&#39;'
    }[t]));
    return tempStr.replace(new RegExp(brPlaceholder, 'g'), '<br>');
}
function getScoreRemark(score) {
  if (score === 100) return "Perfect Score! You are a genius! ";
  if (score >= 90) return "Excellent work! You really know your stuff. ";
  if (score >= 80) return "Great job! Very impressive. ";
  if (score >= 70) return "Good score! Keep up the good work. ";
  if (score >= 50) return "Not bad, but there's room for improvement. Keep studying! ";
  if (score >= 30) return "You've got the basics, but review is needed. Don't give up! ";
  return "This was a tough one. Review your mistakes and try again! ";
}

// --- Audio Controls ---
function setupAudio() {
    const audio = document.getElementById('bg-music');
    if (musicBase64 && musicBase64.includes('data:audio')) {
      audio.src = musicBase64;
    }
    audio.muted = state.isMuted;
    if (!state.isMuted) {
      audio.play().catch(e => console.log("Autoplay was prevented."));
    }
}
window.toggleMute = function() {
    state.isMuted = !state.isMuted;
    const audio = document.getElementById('bg-music');
    audio.muted = state.isMuted;
    if (!state.isMuted) {
        audio.play().catch(e => console.log("Could not play audio."));
    } else {
        audio.pause();
    }
    saveSettings();
    render();
}
window.toggleDarkMode = function() {
    state.dark = !state.dark;
    saveSettings();
    render();
}


// --- Core Rendering Engine ---
function render() {
  document.body.className = state.dark ? "dark" : "";
  const app = document.getElementById("app");
  app.innerHTML = ''; // Clear previous content

  switch (state.view) {
    case "menu": renderMenu(app); break;
    case "view_bank": renderViewBank(app); break;
    case "memories_list": renderMemoriesList(app); break;
    case "study_setup": renderRangeSetup(app, 'study'); break;
    case "study_test": renderFullTest(app); break;
    case "test_setup": renderRangeSetup(app, 'test'); break;
    case "test_test": renderFullTest(app); break; // Reuses study test view
    case "sixty_setup": renderSixtySetup(app); break;
    case "paged_test": renderPagedTest(app); break; // For 60/60, time limit, memory tests
    case "timelimit_setup": renderTimeLimitSetup(app); break;
    case "memories_setup": renderMemoriesSetup(app); break;
    case "results": renderResults(app); break;
    case "instruction": renderInstruction(app); break;
    case "edit_question": renderEdit(app); break;
    default: app.innerHTML = "<h2>Unknown Page</h2>"; break;
  }
}
function renderHeader(title) {
    return `
    <div class="global-header">
      <button class="btn-secondary" onclick="setView('menu')"> Back to Main Menu</button>
      <div class="header-icons">
        <button class="icon-btn" onclick="toggleMute()">${state.isMuted ? '' : ''}</button>
        <button class="icon-btn" onclick="toggleDarkMode()">${state.dark ? "" : ""}</button>
      </div>
    </div>
    <h1>${escapeHtml(title)}</h1>
  `;
}

// --- View-Specific Renderers ---
function renderMenu(app) {
 app.innerHTML = `
    <div class="global-header">
      <h1 style="margin: 0;" contenteditable="true" onblur="updateTitle(this)">${escapeHtml(state.quizTitle)}</h1>
      <div class="header-icons">
        <button class="icon-btn" onclick="toggleMute()">${state.isMuted ? '' : ''}</button>
        <button class="icon-btn" onclick="toggleDarkMode()">${state.dark ? "" : ""}</button>
      </div>
    </div>
    <p>Number of Questions in the Main Bank: <b>${state.mainQuestionBank.length} Questions</b></p>
    <div class="main-menu">
      <div class="menu-button" onclick="setView('study_setup')"><br>Study Question</div>
      <div class="menu-button" onclick="setView('test_setup')"><br>Test Question</div>
      <div class="menu-button" onclick="setView('sixty_setup')"><br>60/60 Test</div>
      <div class="menu-button" onclick="setView('timelimit_setup')"><br>Time Limit Test</div>
      <div class="menu-button" onclick="setView('memories_list')"><br>Memories List</div>
      <div class="menu-button" onclick="setView('memories_setup')"><br>Memories Test</div>
      <div class="menu-button" onclick="setView('view_bank')"><br>View Question Bank</div>
      <div class="menu-button" onclick="setView('instruction')"><br>Instruction</div>
    </div>
    <div class="notes-section">
      <p><b>Note:</b> For safety reasons (Malware, Malicious Links), please ONLY download the Quiz from an official source.</p>
      <p><b>Note:</b> For iOS, you may need to download an HTML viewer app, then import this file into it. For PC and Android, you can open this file directly in your browser.</p>
      <p><b>Notice:</b> This Quiz is offline. It doesn't require any Internet connection nor does it connect to a server. It runs entirely within this single file.</p>
    </div>
  `;
}
function renderViewBank(app) {
    app.innerHTML = `
        ${renderHeader("Main Question Bank")}
        <button onclick="addNewQuestion()">Add New Question</button>
        <div class="manage-list" style="margin-top: 20px;">
          ${state.mainQuestionBank.map((q, i) => renderManageQuestion(q, i, true)).join('')}
        </div>
    `;
}
function renderManageQuestion(q, index, isMainBankView) {
    const originalIndex = isMainBankView ? index : state.memoriesList[index];
    const questionData = state.mainQuestionBank[originalIndex];
    if (!questionData) return ''; // Safety check

    return `
    <div class="question-card">
      <div style="display: flex; justify-content: space-between; align-items: flex-start;">
        <div style="font-weight:bold;">Q${originalIndex + 1}: ${escapeHtml(questionData.question)}</div>
        <div class="manage-actions">
          <button onclick="editQuestion(${originalIndex})">Edit</button>
          <button class="btn-danger" onclick="${isMainBankView ? `deleteQuestion(${originalIndex})` : `deleteFromMemory(${index})`}">Delete</button>
        </div>
      </div>
      ${questionData.img ? `<img src="${questionData.img}" class="question-img">` : ""}
      <ol type="A" style="margin:12px 0 0 20px; padding-left: 0;">
        ${questionData.responses.map((r, j) => `
          <li style="padding: 4px 0; ${j === questionData.correct ? 'font-weight:600; color:var(--correct);' : ''}">
            ${escapeHtml(r)}
          </li>`).join('')}
      </ol>
    </div>
  `;
}
function renderMemoriesList(app) {
    let content = `
        ${renderHeader("Memories List")}
        <div class="setup-form">
            <div class="form-group">
                <label for="add-mem-input">Add questions from Main Bank by number (e.g., "45, 52, 60-70"):</label>
                <input type="text" id="add-mem-input" placeholder="Enter numbers or ranges...">
            </div>
            <button onclick="addQuestionsToMemory()">Add to List</button>
        </div>
        <div class="manage-list" style="margin-top: 20px;">
    `;
    if (state.memoriesList.length === 0) {
        content += `<p>Your memories list is empty. Incorrectly answered questions from tests will appear here.</p>`;
    } else {
        content += state.memoriesList.map((qIndex, i) => renderManageQuestion(null, i, false)).join('');
    }
    content += `</div>`;
    app.innerHTML = content;
}
function renderRangeSetup(app, mode) {
    app.innerHTML = `
        ${renderHeader(mode === 'study' ? 'Study Question Setup' : 'Test Question Setup')}
        <div class="setup-form">
            <p>Select the questions you want to practice.</p>
            <div id="range-container">
                <div class="form-group range-input">
                    <label>From</label>
                    <input type="number" class="range-from" min="1" max="${state.mainQuestionBank.length}" placeholder="1">
                    <label>To</label>
                    <input type="number" class="range-to" min="1" max="${state.mainQuestionBank.length}" placeholder="${state.mainQuestionBank.length}">
                </div>
            </div>
            <button onclick="startTestFromRange('${mode}')">Start ${mode === 'study' ? 'Study' : 'Test'}</button>
            <button class="btn-secondary" onclick="startTestFromRange('${mode}', true)">${mode === 'study' ? 'Study' : 'Test'} Whole Bank</button>
        </div>
    `;
}
function renderFullTest(app) {
    const { mode } = state.currentTestConfig;
    app.innerHTML = `
        ${renderHeader(mode === 'study' ? 'Study Session' : 'Test Session')}
        <div id="full-test-container">
            ${state.testQuestions.map((q, i) => renderFullTestQuestion(q, i, mode)).join('')}
        </div>
        <button onclick="finishAttempt()" style="margin-top: 20px; width: 100%; padding: 15px; font-size: 1.2em;">Finish Attempt</button>
    `;
}
function renderFullTestQuestion(q, index, mode) {
    const answer = state.answers[index];
    const isAnswered = answer !== undefined;

    return `
    <div class="question-card" id="q-card-${index}">
      <h3 style="font-weight:bold;">
        ${mode === 'study' ? `Q${q.originalIndex + 1}: ` : ''}${escapeHtml(q.question)}
      </h3>
      ${q.img ? `<img src="${q.img}" class="question-img">` : ''}
      <div class="responses">
        ${q.shuffledResponses.map((r, j) => {
            const isCorrect = q.shuffledMap[j] === q.correct;
            const isSelected = j === answer;
            let cls = 'response-box';
            if (isAnswered) {
                if (isSelected && isCorrect) cls += ' correct';
                else if (isSelected && !isCorrect) cls += ' wrong';
                else if (isCorrect) cls += ' correct'; // Show correct one if user was wrong
            }
            return `
            <div class="${cls}" onclick="handleImmediateFeedback(${index}, ${j})">
              <span class="response-prefix">${String.fromCharCode(65 + j)})</span>
              <span>${escapeHtml(r)}</span>
            </div>`;
        }).join('')}
      </div>
    </div>
    `;
}
function renderSixtySetup(app) {
    app.innerHTML = `
        ${renderHeader("60/60 Test Setup")}
        <div class="setup-form">
            <div class="form-group">
                <label for="difficulty">Select Difficulty:</label>
                <select id="difficulty" style="width:100%; padding: 10px; font-size: 1em;">
                    <option value="60">Normal (60s / Q)</option>
                    <option value="45">Lag lag lag (45s / Q)</option>
                    <option value="30">Why so slow? (30s / Q)</option>
                    <option value="20">Stuck n Suprise (20s / Q)</option>
                    <option value="15">I will send to Jesus (15s / Q)</option>
                    <option value="10">Asian diff (10s / Q)</option>
                </select>
            </div>
            <button onclick="startPagedTest('sixty')" ${state.mainQuestionBank.length < 60 ? 'disabled' : ''}>
              Start 60/60 Test
            </button>
            ${state.mainQuestionBank.length < 60 ? `<p style="color:var(--error);">You need at least 60 questions in the main bank to start this mode.</p>` : ''}
        </div>
    `;
}
function renderTimeLimitSetup(app) {
    app.innerHTML = `
        ${renderHeader("Time Limit Test Setup")}
        <div class="setup-form">
            <div class="form-group">
                <label>Select Question Range:</label>
                <div class="range-input">
                    <label>From</label>
                    <input type="number" id="range-from" min="1" max="${state.mainQuestionBank.length}" value="1">
                    <label>To</label>
                    <input type="number" id="range-to" min="1" max="${state.mainQuestionBank.length}" value="${state.mainQuestionBank.length}">
                </div>
            </div>
            <div class="form-group">
                <label for="time-limit">Time per question (seconds):</label>
                <input type="number" id="time-limit" min="5" value="30">
            </div>
            <button onclick="startPagedTest('timelimit')">Start Time Limit Test</button>
            <button class="btn-secondary" onclick="startPagedTest('timelimit', true)">Test Whole Bank</button>
        </div>
    `;
}
function renderMemoriesSetup(app) {
    app.innerHTML = `
        ${renderHeader("Memories Test Setup")}
        <div class="setup-form">
            <div class="form-group">
                <label>Test Mode:</label>
                <select id="mem-test-mode" style="width:100%; padding: 10px; font-size: 1em;">
                    <option value="memory_only">Only Questions from Memories List (${state.memoriesList.length} questions)</option>
                    <option value="memory_plus">Memories List + Random from Main Bank</option>
                </select>
            </div>
            <div class="form-group" id="extra-questions-group" style="display:none;">
                <label for="extra-questions">Number of random questions to add from Main Bank:</label>
                <input type="number" id="extra-questions" min="1" value="10" max="${state.mainQuestionBank.length - state.memoriesList.length}">
            </div>
            <button onclick="startPagedTest('memory')" ${state.memoriesList.length === 0 ? 'disabled' : ''}>Start Memories Test</button>
             ${state.memoriesList.length === 0 ? `<p style="color:var(--error);">Your memories list is empty. Add questions to start.</p>` : ''}
        </div>
    `;
    // Add event listener to show/hide extra questions input
    setTimeout(() => {
        const select = document.getElementById('mem-test-mode');
        const extraGroup = document.getElementById('extra-questions-group');
        if (select) {
            select.addEventListener('change', (e) => {
                extraGroup.style.display = e.target.value === 'memory_plus' ? 'block' : 'none';
            });
        }
    }, 0);
}
function renderPagedTest(app) {
    clearTimeout(state.timerId);
    const q = state.testQuestions[state.idx];
    if (!q) {
        finishAttempt();
        return;
    }
    const answered = state.answers[state.idx] !== undefined;
    const { timePerQuestion, total, timeLeft } = state.currentTestConfig;

    app.innerHTML = `
        ${renderHeader(state.currentTestConfig.title)}
        <div class="progress-bar-wrap"><div class="progress-bar" style="width:${((state.idx) / total) * 100}%"></div></div>
        <div style="display: flex; justify-content: space-between; margin-bottom: 10px; font-weight: 500;">
            <span>Question ${state.idx + 1} of ${total}</span>
            ${timePerQuestion ? `<span>Time left: <b>${timeLeft}s</b></span>` : ''}
        </div>
        <div class="question-card">
            <h3 style="font-weight:bold;">${escapeHtml(q.question)}</h3>
            ${q.img ? `<img src="${q.img}" class="question-img">` : ''}
            <div class="responses">
                ${q.shuffledResponses.map((r, j) => {
                    const isCorrect = q.shuffledMap[j] === q.correct;
                    const isSelected = state.answers[state.idx] === j;
                    let cls = 'response-box';
                    if (answered) {
                        if (isSelected && isCorrect) cls += ' correct';
                        else if (isSelected && !isCorrect) cls += ' wrong';
                        else if (isCorrect) cls += ' correct';
                    }
                    return `
                    <div class="${cls}" onclick="handlePagedAnswer(${j})">
                        <span class="response-prefix">${String.fromCharCode(65 + j)})</span>
                        <span>${escapeHtml(r)}</span>
                    </div>`;
                }).join('')}
            </div>
        </div>
        ${answered ? `<button onclick="nextPagedQuestion()" style="width:100%; padding: 15px; font-size: 1.2em;">${state.idx + 1 === total ? 'Finish' : 'Next Question'}</button>` : ''}
    `;

    if (timePerQuestion && !answered) {
        state.timerId = setTimeout(pagedTimerTick, 1000);
    }
}
function renderResults(app) {
    const { correctCount, total, wrongAnswers } = state.currentTestConfig.results;
    const score = total > 0 ? Math.round((correctCount / total) * 100) : 0;
    app.innerHTML = `
        ${renderHeader("Test Results")}
        <div class="score-bar">${correctCount} / ${total} (${score}%)</div>
        <div class="score-remark">${getScoreRemark(score)}</div>
        <div class="progress-bar-wrap" style="margin-top: 20px;"><div class="progress-bar" style="width:${score}%"></div></div>
        <div style="margin-top: 30px; text-align: center;">
            <button onclick="retryTest()">Try Again</button>
            <button class="btn-secondary" onclick="setView('menu')">Back to Main Menu</button>
        </div>
        <div style="margin-top: 30px;">
            <h3 style="border-bottom: 2px solid var(--border); padding-bottom: 10px;">
                Questions Answered Incorrectly (${wrongAnswers.length})
            </h3>
            ${wrongAnswers.length === 0
                ? `<p style="color: var(--correct); font-weight: 600;">Congratulations! You answered all questions correctly! </p>`
                : wrongAnswers.map(item => renderWrongReview(item.q)).join('')
            }
        </div>
    `;
}

function renderWrongReview(q) {
    const questionData = state.mainQuestionBank[q.originalIndex];
    if (!questionData) return ''; // Should not happen

    return `
    <div class="question-card">
        <div style="font-weight:600;">Q${q.originalIndex + 1}: ${escapeHtml(questionData.question)}</div>
        ${questionData.img ? `<img src="${questionData.img}" class="question-img">`:''}
        <div class="responses">
            ${questionData.responses.map((r,j)=>{
                const isCorrect = (j === questionData.correct);
                let cls = "response-box";
                if(isCorrect) {
                    cls += " correct";
                }
                return `<div class="${cls}" style="cursor:default;">
                            <span class="response-prefix">${String.fromCharCode(65+j)})</span>
                            <span>${escapeHtml(r)}</span>
                        </div>`;
            }).join('')}
        </div>
    </div>`;
}

function renderInstruction(app) {
    app.innerHTML = `
    ${renderHeader("Instructions")}
    <div class="instruction-page">
      <p>Welcome to the Multiple Choice Question Preparation tool! Here's how to use the different features:</p>

      <h3> Study Question</h3>
      <p>This mode is for practice. You can choose to study all questions or a specific range. Your answers are checked immediately. Incorrectly answered questions are added to your "Memories List".</p>

      <h3> Test Question</h3>
      <p>This mode simulates a real test. Questions and answer options are randomized. You won't see if you're right or wrong until you finish. Your score and incorrect answers are shown at the end.</p>

      <h3> 60/60 Test</h3>
      <p>A fast-paced challenge where you answer 60 random questions from the bank. Each question has a time limit based on the difficulty you select. Great for testing your speed and accuracy under pressure.</p>

      <h3> Time Limit Test</h3>
      <p>Similar to the "Test Question" mode, but you can set a custom time limit for each question. This is perfect for practicing under specific time constraints.</p>

      <h3> Memories List</h3>
      <p>This is your personal list of challenging questions. Any question you get wrong in a test is automatically added here. You can also add questions manually. Use the "Memories Test" to focus on these questions.</p>

      <h3> Memories Test</h3>
      <p>A targeted test to help you conquer your difficult questions. You can choose to test only the questions in your "Memories List", or mix them with a set number of random questions from the main bank.</p>

      <h3> View Question Bank</h3>
      <p>Here you can see all the questions available in the quiz. You can add new questions, edit existing ones, or delete them. This is the master list for all tests.</p>
    </div>
  `;
}

function renderEdit(app) {
    const q = state.editQ;
    if (!q) {
        setView('view_bank');
        return;
    }
    app.innerHTML = `
        ${renderHeader(state.editIdx === -1 ? 'Add New Question' : `Edit Question ${state.editIdx + 1}`)}
        <div class="setup-form">
            <div class="form-group">
                <label for="edit-q-text">Question Text (use &lt;br&gt; for line breaks):</label>
                <textarea id="edit-q-text" rows="3">${escapeHtml(q.question)}</textarea>
            </div>
            <div class="form-group">
                <label for="edit-q-img">Image URL (optional):</label>
                <input type="text" id="edit-q-img" value="${q.img || ''}">
            </div>
            <div id="responses-editor">
                ${q.responses.map((r, i) => `
                    <div class="form-group">
                        <label>Response ${i + 1}:</label>
                        <input type="text" class="response-input" value="${escapeHtml(r)}">
                    </div>
                `).join('')}
            </div>
            <div class="form-group">
                <label for="edit-q-correct">Correct Answer (1-${q.responses.length}):</label>
                <input type="number" id="edit-q-correct" min="1" max="${q.responses.length}" value="${q.correct + 1}">
            </div>
            <button onclick="saveQuestion()">Save Question</button>
            <button class="btn-secondary" onclick="setView('view_bank')">Cancel</button>
        </div>
    `;
}


// --- Event Handlers & Logic ---
function setView(view) {
    if (view === 'view_bank') {
        // Clear local storage except for memories list
        const memories = localStorage.getItem(MEMORY_LIST_KEY);
        localStorage.clear();
        if (memories) {
            localStorage.setItem(MEMORY_LIST_KEY, memories);
        }
    }
    state.view = view;
    render();
}

function updateTitle(element) {
    state.quizTitle = element.innerText;
}

function addNewQuestion() {
    state.editIdx = -1;
    state.editQ = {
        question: "",
        img: "",
        responses: ["", "", "", ""],
        correct: 0
    };
    setView('edit_question');
}

function editQuestion(index) {
    state.editIdx = index;
    // Deep copy the question to avoid modifying the original during editing
    state.editQ = JSON.parse(JSON.stringify(state.mainQuestionBank[index]));
    setView('edit_question');
}

function deleteQuestion(index) {
    if (confirm(`Are you sure you want to delete Question ${index + 1}?`)) {
        state.mainQuestionBank.splice(index, 1);
        // Also remove from memories list if it's there
        state.memoriesList = state.memoriesList.filter(memIndex => memIndex !== index);
        state.memoriesList = state.memoriesList.map(memIndex => memIndex > index ? memIndex - 1 : memIndex);
        saveData();
        render();
    }
}

function saveQuestion() {
    const questionText = document.getElementById('edit-q-text').value;
    const imgUrl = document.getElementById('edit-q-img').value;
    const correct = parseInt(document.getElementById('edit-q-correct').value, 10) - 1;
    const responses = Array.from(document.querySelectorAll('.response-input')).map(input => input.value);

    if (!questionText || responses.some(r => !r) || isNaN(correct) || correct < 0 || correct >= responses.length) {
        alert("Please fill out all fields correctly.");
        return;
    }

    const newQuestion = {
        question: questionText,
        img: imgUrl,
        responses: responses,
        correct: correct
    };

    if (state.editIdx === -1) { // Adding new question
        state.mainQuestionBank.push(newQuestion);
    } else { // Editing existing question
        state.mainQuestionBank[state.editIdx] = newQuestion;
    }
    saveData();
    setView('view_bank');
}


function addQuestionsToMemory() {
    const input = document.getElementById('add-mem-input').value;
    if (!input) return;

    const numbersToAdd = new Set();
    const parts = input.split(',');

    parts.forEach(part => {
        part = part.trim();
        if (part.includes('-')) {
            const [start, end] = part.split('-').map(n => parseInt(n.trim(), 10));
            if (!isNaN(start) && !isNaN(end) && start <= end) {
                for (let i = start; i <= end; i++) {
                    if (i >= 1 && i <= state.mainQuestionBank.length) {
                        numbersToAdd.add(i - 1);
                    }
                }
            }
        } else {
            const num = parseInt(part, 10);
            if (!isNaN(num) && num >= 1 && num <= state.mainQuestionBank.length) {
                numbersToAdd.add(num - 1);
            }
        }
    });

    const currentMemorySet = new Set(state.memoriesList);
    numbersToAdd.forEach(num => currentMemorySet.add(num));
    state.memoriesList = Array.from(currentMemorySet).sort((a, b) => a - b);

    saveData();
    render();
}

function deleteFromMemory(index) {
     if (confirm(`Are you sure you want to delete this question from your Memories List?`)) {
        state.memoriesList.splice(index, 1);
        saveData();
        render();
    }
}

function startTestFromRange(mode, wholeBank = false) {
    let from = 1, to = state.mainQuestionBank.length;
    if (!wholeBank) {
        from = parseInt(document.querySelector('.range-from').value || 1, 10);
        to = parseInt(document.querySelector('.range-to').value || state.mainQuestionBank.length, 10);
    }

    if (from < 1 || to > state.mainQuestionBank.length || from > to) {
        alert("Invalid range selected.");
        return;
    }

    let questionIndices = [];
    for (let i = from - 1; i < to; i++) {
        questionIndices.push(i);
    }

    let testQuestions = questionIndices.map(originalIndex => {
        const q = state.mainQuestionBank[originalIndex];
        return { ...q, originalIndex };
    });

    if (mode === 'test') {
        testQuestions = shuffle(testQuestions);
    }

    state.testQuestions = testQuestions.map(q => {
        const shuffledResponses = shuffle(q.responses);
        const shuffledMap = shuffledResponses.map(r => q.responses.indexOf(r));
        return { ...q, shuffledResponses, shuffledMap };
    });

    state.answers = new Array(state.testQuestions.length);
    state.currentTestConfig = { mode, from, to, wholeBank };
    setView(mode === 'study' ? 'study_test' : 'test_test');
}


function handleImmediateFeedback(questionIndex, responseIndex) {
    if (state.answers[questionIndex] !== undefined) return; // Already answered

    state.answers[questionIndex] = responseIndex;
    render(); // Re-render to show feedback
}

function finishAttempt() {
    let correctCount = 0;
    const wrongAnswers = [];
    const newMemoryItems = new Set(state.memoriesList);

    state.testQuestions.forEach((q, i) => {
        const selectedResponseIndex = state.answers[i];
        if(selectedResponseIndex === undefined) {
             wrongAnswers.push({ q });
             newMemoryItems.add(q.originalIndex);
             return;
        }

        const originalResponseIndex = q.shuffledMap[selectedResponseIndex];
        const isCorrect = originalResponseIndex === q.correct;

        if (isCorrect) {
            correctCount++;
        } else {
            wrongAnswers.push({ q });
            newMemoryItems.add(q.originalIndex);
        }
    });

    state.memoriesList = Array.from(newMemoryItems).sort((a, b) => a - b);
    saveData();

    state.currentTestConfig.results = {
        correctCount,
        total: state.testQuestions.length,
        wrongAnswers
    };

    setView('results');
}

function retryTest() {
    const { mode, wholeBank, from, to, timePerQuestion } = state.currentTestConfig;
    if (mode === 'study' || mode === 'test') {
        startTestFromRange(mode, wholeBank);
    } else if (mode === 'sixty' || mode === 'timelimit' || mode === 'memory') {
        startPagedTest(mode, wholeBank);
    }
}
function startPagedTest(mode, wholeBank = false) {
    let questions = [];
    let config = { mode };

    if (mode === 'sixty') {
        const time = parseInt(document.getElementById('difficulty').value, 10);
        questions = shuffle(state.mainQuestionBank).slice(0, 60).map((q, i) => ({...q, originalIndex: state.mainQuestionBank.indexOf(q)}));
        config.title = "60/60 Test";
        config.timePerQuestion = time;
    } else if (mode === 'timelimit') {
        const time = parseInt(document.getElementById('time-limit').value, 10);
        let from = 1, to = state.mainQuestionBank.length;
        if (!wholeBank) {
            from = parseInt(document.getElementById('range-from').value, 10);
            to = parseInt(document.getElementById('range-to').value, 10);
        }
        let indices = [];
        for (let i = from - 1; i < to; i++) indices.push(i);
        questions = shuffle(indices).map(i => ({...state.mainQuestionBank[i], originalIndex: i}));
        config.title = "Time Limit Test";
        config.timePerQuestion = time;
        config.from = from;
        config.to = to;
        config.wholeBank = wholeBank;
    } else if (mode === 'memory') {
        const testMode = document.getElementById('mem-test-mode').value;
        let memQuestions = state.memoriesList.map(i => ({...state.mainQuestionBank[i], originalIndex: i}));

        if (testMode === 'memory_plus') {
            const extraCount = parseInt(document.getElementById('extra-questions').value, 10);
            const bankIndices = state.mainQuestionBank.map((_,i) => i);
            const nonMemoryIndices = bankIndices.filter(i => !state.memoriesList.includes(i));
            const extraIndices = shuffle(nonMemoryIndices).slice(0, extraCount);
            const extraQuestions = extraIndices.map(i => ({...state.mainQuestionBank[i], originalIndex: i}));
            memQuestions = memQuestions.concat(extraQuestions);
        }
        questions = shuffle(memQuestions);
        config.title = "Memories Test";
    }

    state.testQuestions = questions.map(q => {
        const shuffledResponses = shuffle(q.responses);
        const shuffledMap = shuffledResponses.map(r => q.responses.indexOf(r));
        return { ...q, shuffledResponses, shuffledMap };
    });

    state.answers = new Array(state.testQuestions.length);
    state.idx = 0;
    config.total = state.testQuestions.length;
    if (config.timePerQuestion) {
        config.timeLeft = config.timePerQuestion;
    }
    state.currentTestConfig = config;
    setView('paged_test');
}


function handlePagedAnswer(responseIndex) {
    if (state.answers[state.idx] !== undefined) return;
    state.answers[state.idx] = responseIndex;
    clearTimeout(state.timerId);
    render();
}

function nextPagedQuestion() {
    if (state.idx < state.testQuestions.length - 1) {
        state.idx++;
        if (state.currentTestConfig.timePerQuestion) {
            state.currentTestConfig.timeLeft = state.currentTestConfig.timePerQuestion;
        }
        render();
    } else {
        finishAttempt();
    }
}

function pagedTimerTick() {
    state.currentTestConfig.timeLeft--;
    if (state.currentTestConfig.timeLeft <= 0) {
        state.answers[state.idx] = -1; // Mark as incorrect (timeout)
        nextPagedQuestion();
    } else {
        render();
    }
}

// --- Initial Load ---
window.onload = () => {
  loadData();
  setupAudio();
  render();
};
</script>
</body>
</html>